{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Analysis of Measure Summaries from qualitymeasures.ahrq.gov "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"../scripts/archive-status-ahrq-measure-summaries-seeds.uniq.with_mdt.tsv\") as f:\n",
    "    data = f.read()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "from urllib.parse import urlparse\n",
    "\n",
    "identifiers = []\n",
    "mementocounts = []\n",
    "timemaps = []\n",
    "totalcount = 0\n",
    "notarchived = []\n",
    "alldata = {}\n",
    "\n",
    "for line in data.splitlines():\n",
    "    line = line.strip()\n",
    "    row = line.split('\\t')\n",
    "    \n",
    "    if row[1] == 'ARCHIVED':\n",
    "        s2 = row[0].replace('https://qualitymeasures.ahrq.gov/summaries/summary/', '')\n",
    "        try:\n",
    "            identifier = int(s2[:s2.find('/')])\n",
    "        except ValueError:\n",
    "            print(\"failed on URI: \" + row[0])\n",
    "#         mementocount = int(row[2].replace(\"mementos\", \"\").strip())\n",
    "        timemap = eval(row[3])\n",
    "        mementocount = len(timemap)\n",
    "        \n",
    "        identifiers.append( identifier )\n",
    "        mementocounts.append( mementocount )\n",
    "        \n",
    "        timemaps.append( timemap )\n",
    "        \n",
    "        alldata[identifier] = timemap\n",
    "        \n",
    "    elif row[1] == 'NOT ARCHIVED':\n",
    "        notarchived.append(row[0])\n",
    "        \n",
    "    totalcount += 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2509"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(identifiers)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2509"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(mementocounts)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2509"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(timemaps)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2533"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "totalcount"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "24"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(notarchived)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.0094749309119621"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(notarchived) / totalcount"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.990525069088038"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(timemaps) / totalcount"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "15"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "max(mementocounts)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "min(mementocounts)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "26637"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "min(identifiers)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "51250"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "max(identifiers)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "counts: [ 81. 125.   0. 521.   0. 802.   0. 438. 208.   0. 142.   0.  78.   0.\n",
      "  16.   0.   1.   1.   0.  12.   0.   8.   0.  55.  21.]\n",
      "bars: [ 1.    1.56  2.12  2.68  3.24  3.8   4.36  4.92  5.48  6.04  6.6   7.16\n",
      "  7.72  8.28  8.84  9.4   9.96 10.52 11.08 11.64 12.2  12.76 13.32 13.88\n",
      " 14.44 15.  ]\n",
      "bins: <a list of 25 Patch objects>\n",
      "max counts: 802.0\n",
      "index of max counts: 5\n",
      "bars[ind]: 3.8000000000000003\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# plt.hist(mementocounts, bins=25, color=\"#b2df8a\")\n",
    "# plt.xlabel(\"number of mementos\")\n",
    "# plt.ylabel(\"count of URIs \\n with this number of mementos\")\n",
    "# plt.title(\"Histogram of the number of mementos per URI\\nfor qualitymeasures.ahrq.gov\")\n",
    "\n",
    "counts, bars, bins = plt.hist(mementocounts, bins=25, color=\"#b2df8a\")\n",
    "plt.xlabel(\"number of mementos\")\n",
    "plt.ylabel(\"count of URIs \\n with this number of mementos\")\n",
    "plt.title(\"Histogram of the number of mementos per URI\\nfor measure summaries\\n at qualitymeasures.ahrq.gov\")\n",
    "print(\"counts: {}\".format(counts))\n",
    "print(\"bars: {}\".format(bars))\n",
    "print(\"bins: {}\".format(bins))\n",
    "print(\"max counts: {}\".format(max(counts)))\n",
    "ind = counts.tolist().index(max(counts))\n",
    "print(\"index of max counts: {}\".format(ind))\n",
    "print(\"bars[ind]: {}\".format(bars[ind]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Text(0,0.5,'document identifier')"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.scatter(mementocounts, identifiers)\n",
    "plt.xlabel(\"number of mementos\")\n",
    "plt.ylabel(\"document identifier\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "all_mdts = []\n",
    "\n",
    "for timemap in timemaps:\n",
    "    for memento in timemap:\n",
    "        all_mdts.append(memento['datetime'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "11656"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(all_mdts)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'2016-09-30T14:38:02Z'"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "min(all_mdts)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'2018-06-25T16:41:31Z'"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "max(all_mdts)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "from datetime import datetime\n",
    "\n",
    "ids2mementos = []\n",
    "mdt2ids = []\n",
    "monthbuckets = {}\n",
    "\n",
    "for identifier in alldata:\n",
    "    timemap = alldata[identifier]\n",
    "    \n",
    "    for memento in timemap:\n",
    "        \n",
    "        ids2mementos.append(identifier)\n",
    "        \n",
    "        mdt = datetime.strptime(memento['datetime'], '%Y-%m-%dT%H:%M:%SZ')\n",
    "        \n",
    "        mdt2ids.append(mdt)\n",
    "        monthbuckets.setdefault( datetime.strptime(mdt.strftime('%Y-%m'), '%Y-%m'), 0)\n",
    "        monthbuckets[ datetime.strptime(mdt.strftime('%Y-%m'), '%Y-%m') ] += 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.dates as mdates\n",
    "\n",
    "years = mdates.YearLocator()\n",
    "months = mdates.MonthLocator()\n",
    "yearsFmt = mdates.DateFormatter('%Y-%m')\n",
    "\n",
    "fig, ax = plt.subplots()\n",
    "\n",
    "ax.scatter(mdt2ids, ids2mementos)\n",
    "\n",
    "ax.xaxis.set_major_locator(years)\n",
    "ax.xaxis.set_major_formatter(yearsFmt)\n",
    "ax.xaxis.set_minor_locator(months)\n",
    "\n",
    "fig.autofmt_xdate()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "hi\n"
     ]
    }
   ],
   "source": [
    "print(\"hi\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "x = []\n",
    "y = []\n",
    "\n",
    "for key in monthbuckets:\n",
    "    x.append(key)\n",
    "    y.append(monthbuckets[key])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAm4AAAJYCAYAAADbi2qjAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADl0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uIDIuMi4yLCBodHRwOi8vbWF0cGxvdGxpYi5vcmcvhp/UCwAAIABJREFUeJzs3XmcZHV97//Xm90FGJARYViGKC5gInpH0GvyCAEFRAkmUYMrelXUq9dwNUQxJqKC0Z8iamJMUBAEFXFHgxLc4i4MiigYdIThNwwDDPuOLJ/7x/k21DTdPTXQ1d1n5vV8POrRVd9zzvd86lR117vPUt9UFZIkSZr71pvtAiRJkjQcg5skSVJPGNwkSZJ6wuAmSZLUEwY3SZKknjC4SZIk9YTBTZKGlGRpkqevwfxHJrkqyeWjrEtzS5K3Jvn4bNehtZPBTWuN9qH6+yRbjWv/eZJKsnB2KptYkiOSnPwA+9g9yelJrktyTZKzkrx8umqcYr3fTfLKKaYvbNv8pnZbmuQt07z+SvKEce1fau17TsM6Tkhy5ANYfgfgTcAuVfWIB1pP67OSXJlkg4G2DVtbr7+UM8l2Sb7Qgu71SX6V5GWzXdf9UVXvrqpJfz+kB8LgprXNxcALxh4k+UPgwbNXzugkeSrwbeC/gEcBDwNeCzxzNusaZ15VPZTuNfnHJPutaQdJ1p9k0m+Alw7M9zDgqcDK+1PoCOwAXF1VV67pgoPBbALXsupr/MzWNmespv7JnAQsA3akey+/BLhiOuuaCffzuUvDqypv3taKG7AUeBtw9kDb+4G/BwpY2No2bu3/P90Hw78BD2rT9gQuBf4OuBJYATwH2J8uKFwDvHWg//WAtwC/A64GTgW2bNMWtvUe3NZ1FfD3bdp+wO+BO4CbgF+09m2B09p6lgCvmuL5/gD4yGq2yataP9e0frcdV9sGA/N+F3hlu/+y1v/76ULBxcAz27SjgLuA21rt/zLBeifq/2zgb9v9xwJntrouBJ4/MN8JwEeB04GbgadP0P93gX9sr9X6re31bblLgT0HXusPApe12weBjce91m8aeK1f3qYd0l6b37fn+NWB99jfAucB1wOfBTaZoL6nA7cCd7flT2jtfw6cD1zXnsPjxr1/39z6vn1w2w3MU3Tv8c8NtH2e9h4faNscOK49p+XAkQPb6ZF0gf9quvfkp+gC9tiyb27L3Nhem70HXpcjB+bbE7h0qvrp3s9foAvTFwNvmOK9ehOw2yTTVlnXwPqe3u4fAXwOOLnV/Uvg0cDh7bVdBuwz7v1zJPCjsdeXLix+CriB7r26cGD+D7U+bgDOAf5kYNoR7TU4uU1/ZWs7eWCep7R1XQf8gvb+HPhdu6jVfTHwotn+W+ptbt9mvQBv3qbrNvaHvH3YPA5Yn+6DeUdWDW7H0IWYLYFN2x/tf2rT9gTupAsFG9IFn5XAp9u8u9J9IO/U5v8b4CfAdnQh4d+Bz7RpC9t6PwY8CHhC+0B7XJu+yh/31vY94F+BTYDd2rr3muC5PpguPP3ZFNtjL7oP5ie12v4Z+N642qYKbne0578+3Z68y4CMn3eSdd/TPxDgacAtwN7AQ9qH4Mvb9Ce2Ondpy55AF4qeRheMJwpG36X7gPxP7g2UZ9HtcRsMbu9sr8/Dgfl0H57vGvdav7O91vu3GrcYqOPIcetd2tazLd3759fAaybZBnuyarB5NF0QfUZb39/RheqNBvo+F9ie9o/EBH0W8Hi6fzjmAVu0+49n1eD2Jbr34kPacz8LeHWb9qhWw8Ztm3wP+GCb9pj22gwG/EdOtD0meH6r1N9eu3Pofpc2Av6ALqDsO8lz+ybwQ+AgYIeptuXg7/vA79JtwL5076lP0oWgv+fe3+OLx71/ltCF2M2BC+j+MXv6wPKfGJj/xXTBbgO6oH857X3Z1n0H3T9467XnfgTtdxtYQBeS92/Tn9Eez2+vzw3AY9q82wC7zvbfUm9z++ahUq2NTqI7hPYMug/W5WMTkoRub8r/raprqupG4N10HxZj7gCOqqo7gFOArYAPVdWNVXU+3R/5sXOrXkO3F+3Sqrqd7g/2c8cdLnlHVd1aVb+g+297lfOyBmrbni6svLmqbquqc4GPM3A4cMAWdB8CK6bYDi8Cjq+qn7XaDgeeugbn+l1SVR+rqruAE+k+VLYectkxV9HtVfs48Jaq+hbwbGBpVX2iqu6sqp/T7ZV53sByX6mqH1bV3VV12xT9fxJ4aZLH0u01+vG46S8C3llVV1bVSuAddIfgxtzRpt9RVafT7X15zGqe04er6rKquoYu9O+2mvnH/DXwH1V1ZntvvZ/uQ/5/jut7WVXdOkU/t7X1/nW7ndbaAEiyNV1IOLSqbq7uUO0xtPd4VS1pNdzetskHgD9ti99FF+h2SbJhVS2tqt8N+fzG1/9kYH5VvbOqfl9VF9H9E3PQJMs+D/g+8A/AxUnOTfLkNVj396vqjKq6k27v23zgPQO/xwuTzBuY/xNV9buquh74OvC7qvrmwPJPHJuxqk6uqqvb+/Voum00+D75cVV9ub1fx792LwZOr6rT2/QzgcV0rxF0e2Ufn+RBVbWi/Y2RJuWxeK2NTqLbi7AT3Qf7oPl0e6vO6TIc0O0RGjyP6uoWVqDbuwarnmtzK/DQdn9H4EtJ7h6YfherBpzBKwpvGVh2vG2BsTA55hJg0QTzXkv3B38b4L+n6O9nYw+q6qYkV9PtAVg+yTKD7qm7qm5p22uy2iezVfsgHLQjsEeS6wbaNqB73cYsG7L/LwJH0+3BOGmC6dvSbcMxl7S2MVePq2+q12fM+Ndz28lmnKqWqro7yTK612PMsM/7k8A/0b133zxu2o50e5lWDLzH1xvruwW7DwF/QrcXeT3aOXJVtSTJoXT/gOya5AzgjVV12ZB1Dda/I7DtuNd5fbpwdh9VdS3daQdvaRcYvR/4cpLthlz3+N/Rqyb4PX4o3eHKieaf7HecJH8LvILuNSxgM7p/6MZM9brtCDwvyQEDbRsC36mqm5P8Nd3h9+OS/BB4U1VN9jstucdNa5+quoTuMMn+dB/sg66i+6O8a1XNa7fNqzuB/v5YRneobt7AbZOqGiYYjb8K8DJgyySbDrTtwAQhq6puAX4M/NUU/V9G96EBQJKH0B3uWU53yA5WvXBjTa58fCBXMC4D/mvcNntoVb12Tftv2+HrdIdyJwpuq2wDuu05bAiZ7qs0x78eoTusOPj6DrvO73PvHtAfjJu2jO6Q/FYD23ezqtq1TX93W88fVtVmdHuE7kl4VfXpqvpj7j3F4L1t0s2s/v0yWP8yusOTg6/zplW1/wTLrdpJ1VV0wW3skPQq624XrMxfXT/TIcmf0B3Wfj7dYfR5dIfyMzDbVK/bMuCkcdvhIVX1HoC2l/AZ3PtP2MdG8kS01jC4aW31Crpzw24ebKyqu+n+MB6T5OEASRYk2fd+ruffgKOS7Nj6mp/kwCGXvYLu8M16rbZldOdg/VOSTZL8UXsek31lyN8BL0tyWLuikiRPSHJKm/4Z4OVJdkuyMd0H9k/b4a+VdIHhxUnWT/K/6M73GdYVdOcs3R9fAx6d5CXtqyw2TPLkJI+7n/29FfjTqlo6wbTPAG9rr8tWdOdbDfsVLA/kOU7kVOBZSfZOsiHduVK3073ma6SqCjgA+PN2f3DaCrpz/45OslmS9ZI8MsnY4dBN6Q4JX59kAXDY2LJJHpNkr/Z+uY17L7CA7vy1/ZNsmeQRwKGrKfMs4MYkb07yoPY+e/xkhz+TvLdN36D98/JaYElVXU13/tkmSZ7Vtt3b6A5XzoRN6c6FXAlskOQf6fa4Detk4IAk+7ZtsEmSPdvXn2yd5MD2T9XtdK/L3VN3p3WdwU1rpXbuyuJJJr+Z7sTknyS5ge6k6NWd1zSZD9GdY/SfSW6kOxF+jyGX/Vz7eXWSsUOaL6A7IfwyuhPM315V35xo4ar6Ed0FCHsBFyW5BjiW7mpM2nL/QHf+2Aq6YDZ4ftGr6D60r6a76GJNAsSH6M7luzbJh9dgOdqh4H1aLZfRHXp8L/fzg7idbzZ+r9OYI+nOJzqP7krDn7W2YRxHd67XdUm+fH9qG1fnhXR7t/6Zbs/vAcABVfX7+9nf+VOcD/VSugsCLqA7DPp5uj060J3n9yS6vUb/wap7pTcG3tPqu5zuwobD27ST6M7RXEoXDD+7mvruojufcTe6PeBX0Z3ruPkkizyY7j1/Hd1FDDvSXYVLOw/tf7flx/YYXzrV+qfRGcA36MLjJXSBdthD2mP/kB1I9w/GyrbsYXSfv+sBb6T7PbiG7lzD107ck9TJuH/WJEmSNEe5x02SJKknDG6SJEk9YXCTJEnqCYObJElSTxjcJK2ifSXEuUluTPKG2a5HMyfJvyX5h9muQ9LkvKpU0iqSHAfcUFX/d7ZrkSStyj1uksbbEbhf4yWOG6O1l9aG53B/tNEIJM1xBjdJ90jybeDPgH9JclOSRyfZPMknk6xMckmSt42N9pDkZUl+mOSYNg7qERP0eUSSzyU5uR1+/WXr9/AkVyZZlmSfgfk3T3JckhVJlic5cixUtBEAvp3k6iRXJflUBgYOb9/Sv7yt58Ike7f2E5IcOTDfnkkuHXi8tC17HnBz+/b+bZN8oT3vi6c6bJxk/yQXtPUuTze25dj2+cG4eSvJowbq+tckX2/b+4dJHpHkg+3Ljf87yRMHll2abqSM85Lc3LbT1m35G5N8M8kWA/N/LsnlSa5P8r0kuw5MOyHJR5OcnuRm4M8m2E7PbofNr0vyo3SjeUy5rSWNlsFN0j2qai+6cTBf38YP/Q3dN/1vTjf805/SfSv/ywcW24Pum+63Bo6apOsD6L55fwvg53TfRr8e3QDr7wT+fWDeE+iGGHoU8ES6URZe2aaFbnD1bYHH0Y31eQR05+YBrweeXFWbAvvSfcv/sF4APAuYRzfs0FfpRgpYAOwNHJrJh0Y7Dnh1W+/jgW+vwXqfTzeE01Z0wx79mG6Eh63oRjz4wLj5/wp4BvBouu36dbpv5Z9Pt00HA+bXgZ3pRkD4GfCpcX29kO4125RxY562wHg88Gq6MW7/HTgtycbTsK0l3U8GN0mTanu6DgIOr6ob23igRwMvGZjtsqr656q6s6punaSr77fBtO+kG+prPvCeqroDOIVuzNZ5SbYG9gcOraqbq+pK4JhWA1W1pKrOrKrb23irH6ALkwB30Q3ZtEuSDduYrL9bg6f74apa1p7Dk4H5VfXOqvp9VV1EN8btQZMse0db72ZVdW1V/WyS+Sbypao6p6puoxvy6baq+mQbMuqzdOF10D9X1RVVtZwuZP+0qn4+sPw981fV8e11u50u4D4hyeCQU1+pqh9W1d1t+UGHAP9eVT+tqruq6kS6YPkUHvi2lnQ/GdwkTWUrYEO6MRrHXEK3F2rMMOM2XjFw/1bgqhZMxh4DPJTu/LoNgRXt8Nx1dHt6Hg7QDgue0g7R3UA3gPdW0IU6uoHPjwCubPNtO/QzXfV57AhsO1ZDq+OtdHsVJ/JXdIHzkiT/leSpa7De8dtm/OOH3p/50w1o/p4kv2vbammbZ6uB+ad67XYE3jRuG2wPbDsN21rS/WRwkzSVq+j2Ju040LYD3UDfY6bz0vRldHt1tqqqee22WVWNnZv17ra+P6yqzegGbc89hVR9uqr+uNVbdIPXQzco+YMH1vOICdY9+DyWARcP1DCvqjatqv0nKrqqzq6qA+kC5peBUydab5KJ1jsqL6Qb3PzpdIe6F46VMTDPVK/dMuCocdvgwVX1GZhyW0saIYObpEm1vWKnAkcl2TTJjsAb6fZ0jWJ9K4D/BI5OslmS9doFCWOHQzcFbgKuT7IAOGxs2XTfP7dXko2B2+j2Pt3dJp8L7J9kyxaeDl1NKWcBN7YT8B/U9l49PsmTx8+YZKMkL0qyeTv0e8PAen8B7JpktySbMMHFGyO0KV0IvpouPL57DZf/GPCaJHuk85Akz2rvg6m2taQRMrhJWp3/Q7fn6CK6E9g/TXfS+qi8FNgIuAC4lu4E/W3atHcATwKuB/4D+OLAchsD76HbS3g53d6vw9u0k+hC1FK6YPjZqQpogfXZwG7Axa3Pj9PtuZrIS4Cl7ZDka4AXtX5+Q3fxxTeB3zLuAoAR+yTdYe3ldNvyJ2uycFUtBl4F/Avd67AEeFmbPNW2ljRCfgGvJElST7jHTZIkqScMbpIkST1hcJMkSeoJg5skSVJPGNwkzbgkC9uYnRu0x19PcvBs17W2aWObPn2265A0fQxu0joq3eDvI/k+tjVVVc9sQypNODC7JKljcJOkGTS2l3Gumat1SVqVwU1aiyX5UJJlSW5Ick6SP2nt+9GNvfnXSW5K8otJln9ikp8luTHJZ9uYlEe2affZM9YOfz6q3X9Wkp+3dS9LcsQUdX43ySuTPA74N+Cpra7rkjw5yRVtwPux+f9yrOa25/BzSU5udf4yyaOTHJ7kyrbufQaW3TzJcUlWtDFPjxzru43S8O0kVye5KsmnkswbWPbNbZkbk1yYZO/WfsLYdmmP90xy6cDjpW3Z84Cbk2yQZNskX0iyMsnFSd4wMP/uSRa3bXdFkg9Mst2mrLfZLcl5Sa5vr+EmgzW2ui4HPtHaD2vb5rIk/2vwNZ1g/U9qr/GN7TX47Ljt8KokS5Jck+S0tPFMk3w0yfvH9fWVJG+caD2S7mVwk9ZuZ9N9+/+WdCMefC7JJlX1DbohkD5bVQ+tqieMXzDJRnTjbp7Ulv8c3WDqw7qZbhSEecCzgNcmec5UC1TVr+lGHvhxq2teVZ1NN2zTPgOzvoRuZIAxB7Q6twB+DpxB9/dtAd3IBf8+MO8JwJ3Ao4Antn5fOfa0gX8CtgUeRzeo+hHQDakFvB54clVtCuzLvQO3D+MFdNthHt3wUF+lG81hAbA3cGiSfdu8HwI+1MZjfST3jn063qT1Dng+sB+wE/BH3Dv6AXRjtm5JN97oIS3Q/y3wDGBnunFOJ15x9/74Et323BL4DPAXA9P3arU9n27ki0uAU9rkz9D905A27xZ0r8PYdEmTMLhJa7GqOrmqrq6qO6vqaLqhih4z5OJPATYEPlhVd1TV5+mC4LDr/m5V/bKq7q6q8+g+rP90dctN4kS6AeVJsiVdaPr0wPTvV9UZVXUnXcCcD7ynjR16CrAwybwkWwP7A4dW1c1VdSVwDHBQq3lJVZ1ZVbdX1UrgAwM130W3/XZJsmFVLa2q363Bc/hwVS2rqluBJwPzq+qdVfX7qrqIbmzQg9q8dwCPSrJVVd1UVRMOV7WaegfXe1lVXUMXFncbmHY38Pa2/K10IesTVfWrqrqZqcdWfQqwQev/jqr6It0Yr2NeBBxfVT+rqtvphsR6apKFwPfpBqb/kzbvc+nC+mVTrE8SBjdprZbkb5P8uh0mu45urM2thlx8W2B5rTou3iVrsO49knynHQq8nm5P2rDrHu9k4IAkD6ELF99vA9KPuWLg/q3AVW280bHHAA+l27O0IbCiHYa9jm5v3MNbzVunOxy8PN24oyeP1VxVS+gGpz8CuLLNt+0aPIdlA/d3BLYdq6HV8VZg6zb9FcCjgf9OcnaSZ0/U4VT1Drh84P4tbTuMWVlVtw083nZcnVO93hO9P5aNm37P8lV1E92e0wVtmVPo9kICvBD41BTrktQY3KS1VLrz2f6OLuhsUVXz6AZnT5tldQMVrwAWjB3OanYYuH8z8OCB9T1i3PKfBk4Dtq+qzenOXQurd5+6qmo58GPgL+kOk540RD8TWQbcDmzVDsPOq6rNqmrXNv3dbf1/2A5Tvniw5qr6dFX9MV3wKuC9bdIq24LuEORUz2sZcPFADfOqatOq2r+t57dV9QK6QPle4PMttI43Zb1DGL+tV9Adbh2zA5Ob6P0xuOxldNsJgFb/w+gGvYduD+xzk+wI7AF8YQ3qltZZBjdp7bUp3blcK4ENkvwjsNnA9CvoDiFO9nfgx235NyTZMMlfArsPTP8FsGuS3doJ70dMsP5rquq2JLvT7VUZxhXAdu0cqkGfpAuifwh8cci+VtH20v0ncHSSzZKs107wHzu8uClwE3B9kgXAYWPLJnlMkr2SbAzcRrcn7+42+Vxg/yRbtgB76GpKOQu4sV0Y8KAk6yd5fJInt3W9OMn8qrobuK4tc/cE/Uxa7/10KvCyJLskeTDw9inm/THd4ePXt4stDmTV98dngJe398fGdCHzp1W1FKCqfg5cBXwcOKOqrkPSahncpLXXGcA3gN/QHbK6jVUPZX2u/bw6yc/GL1xVv6fbw/Uy4BrgrxkITFX1G7oT/78J/BYY/91r/xt4Z5IbgX9k8hPsx/s2cD5weZKrBtq/RLcH50tVdcuQfU3kpcBGwAXAtcDn6U6eB3gH8CS6PZP/waoBcWPgPXRh43K6vWGHt2kn0QXZpXTB8LNTFdAO4z6b7nyzi7k3wGzeZtkPOD/JTXQXKhzUzkEj3dW2Y+eGTVXvGquqrwMfpHsNlrSf90jy1iRfb/OOvT9eQRcuXwx8jW6PJlX1TeAf6PakraC7yOIgVvVpugsgPo2koWTV0xMkaXJJTgAuraq3zdL6fwe8uoUCzYAkBezczvFb3bw/Bf6tqj4x+sqkdZN73CT1QpK/ojsn69urm1czI8mfJnlEO1R6MN3XjXxjtuuS1mZ+U7akOS/Jd4FdgJe08740NzyG7hD4Q4CLgOeOu9pX0jTzUKkkSVJPeKhUkiSpJwxukiRJPbFWnuO21VZb1cKFC2e7DEmSpNU655xzrqqq+cPMu1YGt4ULF7J48eLZLkOSJGm1kgw9nKCHSiVJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknpi5MEtyfpJfp7ka+3xTkl+mmRJks8m2ai1b9weL2nTFw70cXhrvzDJvqOuWZIkaS6aiT1ufwP8euDxe4FjqupRwLXAK1r7K4BrW/sxbT6S7AIcBOwK7Af8a5L1Z6BuSZKkOWWkwS3JdsCzgI+3xwH2Aj7fZjkReE67f2B7TJu+d5v/QOCUqrq9qi4GlgC7j7JuSZKkuWjUe9w+CPwdcHd7/DDguqq6sz2+FFjQ7i8AlgG06de3+e9pn2CZeyQ5JMniJItXrlw53c9DkiRp1o0suCV5NnBlVZ0zqnUMqqpjq2pRVS2aP3/+TKxSkiRpRm0wwr6fBvx5kv2BTYDNgA8B85Js0PaqbQcsb/MvB7YHLk2yAbA5cPVA+5jBZSRJktYZI9vjVlWHV9V2VbWQ7uKCb1fVi4DvAM9tsx0MfKXdP609pk3/dlVVaz+oXXW6E7AzcNao6pYkSZqrRrnHbTJvBk5JciTwc+C41n4ccFKSJcA1dGGPqjo/yanABcCdwOuq6q6ZL1uSJGl2pduptXZZtGhRLV68eLbLkCRJWq0k51TVomHmdeQESZKknjC4SZIk9YTBTZIkqSdm4+IESZKkkfnq0vdNW18HLDxs2vqaDu5xkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1xMiCW5JNkpyV5BdJzk/yjtZ+QpKLk5zbbru19iT5cJIlSc5L8qSBvg5O8tt2O3hUNUuSJM1lG4yw79uBvarqpiQbAj9I8vU27bCq+vy4+Z8J7NxuewAfBfZIsiXwdmARUMA5SU6rqmtHWLskSdKcM7I9btW5qT3csN1qikUOBD7ZlvsJMC/JNsC+wJlVdU0La2cC+42qbkmSpLlqpOe4JVk/ybnAlXTh66dt0lHtcOgxSTZubQuAZQOLX9raJmuXJElap4w0uFXVXVW1G7AdsHuSxwOHA48FngxsCbx5OtaV5JAki5MsXrly5XR0KUmSNKfMyFWlVXUd8B1gv6pa0Q6H3g58Ati9zbYc2H5gse1a22Tt49dxbFUtqqpF8+fPH8XTkCRJmlWjvKp0fpJ57f6DgGcA/93OWyNJgOcAv2qLnAa8tF1d+hTg+qpaAZwB7JNkiyRbAPu0NkmSpHXKKK8q3QY4Mcn6dAHx1Kr6WpJvJ5kPBDgXeE2b/3Rgf2AJcAvwcoCquibJu4Cz23zvrKprRli3JEnSnDSy4FZV5wFPnKB9r0nmL+B1k0w7Hjh+WguUJEnqGUdOkCRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk+MLLgl2STJWUl+keT8JO9o7Tsl+WmSJUk+m2Sj1r5xe7ykTV840Nfhrf3CJPuOqmZJkqS5bJR73G4H9qqqJwC7AfsleQrwXuCYqnoUcC3wijb/K4BrW/sxbT6S7AIcBOwK7Af8a5L1R1i3JEnSnDSy4Fadm9rDDdutgL2Az7f2E4HntPsHtse06Xum+KSJAAAgAElEQVQnSWs/papur6qLgSXA7qOqW5Ikaa4a6TluSdZPci5wJXAm8Dvguqq6s81yKbCg3V8ALANo068HHjbYPsEykiRJ64yRBreququqdgO2o9tL9thRrSvJIUkWJ1m8cuXKUa1GkiRp1szIVaVVdR3wHeCpwLwkG7RJ2wHL2/3lwPYAbfrmwNWD7RMsM7iOY6tqUVUtmj9//kiehyRJ0mwa5VWl85PMa/cfBDwD+DVdgHtum+1g4Cvt/mntMW36t6uqWvtB7arTnYCdgbNGVbckSdJctcHqZ7nftgFObFeArgecWlVfS3IBcEqSI4GfA8e1+Y8DTkqyBLiG7kpSqur8JKcCFwB3Aq+rqrtGWLckSdKcNLLgVlXnAU+coP0iJrgqtKpuA543SV9HAUdNd42SJEl94sgJkiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk+MLLgl2T7Jd5JckOT8JH/T2o9IsjzJue22/8AyhydZkuTCJPsOtO/X2pYkecuoapYkSZrLNhhh33cCb6qqnyXZFDgnyZlt2jFV9f7BmZPsAhwE7ApsC3wzyaPb5I8AzwAuBc5OclpVXTDC2iVJkuackQW3qloBrGj3b0zya2DBFIscCJxSVbcDFydZAuzepi2pqosAkpzS5jW4SZKkdcqMnOOWZCHwROCnren1Sc5LcnySLVrbAmDZwGKXtrbJ2sev45Aki5MsXrly5TQ/A0mSpNk38uCW5KHAF4BDq+oG4KPAI4Hd6PbIHT0d66mqY6tqUVUtmj9//nR0KUmSNKeM8hw3kmxIF9o+VVVfBKiqKwamfwz4Wnu4HNh+YPHtWhtTtEuSJK0zRnlVaYDjgF9X1QcG2rcZmO0vgF+1+6cBByXZOMlOwM7AWcDZwM5JdkqyEd0FDKeNqm5JkqS5apR73J4GvAT4ZZJzW9tbgRck2Q0oYCnwaoCqOj/JqXQXHdwJvK6q7gJI8nrgDGB94PiqOn+EdUuaIV9d+r5p6+uAhYdNW1+SNFeN8qrSHwCZYNLpUyxzFHDUBO2nT7WcJEnSusCREyRJknrC4CZJktQTBjdJkqSeMLhJkiT1hMFNkiSpJwxukiRJPWFwkyRJ6gmDmyRJUk+sNrglOWmYNkmSJI3WMHvcdh18kGR94H+MphxJkiRNZtLgluTwJDcCf5Tkhna7EbgS+MqMVShJkiRgiuBWVf9UVZsC76uqzdpt06p6WFUdPoM1SpIkiSEGma+qw5MsAHYcnL+qvjfKwiRJkrSq1Qa3JO8BDgIuAO5qzQUY3CRJkmbQaoMb8BfAY6rq9lEXI0mSpMkNc1XpRcCGoy5EkiRJUxtmj9stwLlJvgXcs9etqt4wsqokSZJ0H8MEt9PaTZIkSbNomKtKT5yJQiRJkjS1Ya4qvZjuKtJVVNUfjKQiSZIkTWiYQ6WLBu5vAjwP2HI05UiSJGkyq72qtKquHrgtr6oPAs+agdokSZI0YJhDpU8aeLge3R64YfbUSZIkaRoNE8COHrh/J7AUeP5IqpEkSdKkhrmq9M9mohBJkiRNbbXnuCXZPMkHkixut6OTbD4TxUmSJOlewwx5dTxwI93h0ecDNwCfGGVRkiRJuq9hznF7ZFX91cDjdyQ5d1QFSZIkaWLD7HG7Nckfjz1I8jTg1tGVJEmSpIkMs8fttcCJA+e1XQu8bGQVSZIkaULDXFV6LvCEJJu1xzeMvCpJkiTdxzBXlb47ybyquqGqbkiyRZIjZ6I4SZIk3WuYc9yeWVXXjT2oqmuB/UdXkiRJkiYyTHBbP8nGYw+SPAjYeIr5JUmSNALDXJzwKeBbSca+u+3lwImjK0mSJEkTGebihPcm+QXw9Nb0rqo6Y7RlSZIkabxh9rhRVd8AvjHiWiRJkjSFYc5xkyRJ0hxgcJMkSeqJoQ6VJtkIeHR7eGFV3TG6kiRJkjSR1Qa3JHvSXUW6FAiwfZKDq+p7oy1NkiRJg4bZ43Y0sE9VXQiQ5NHAZ4D/McrCJEmStKphznHbcCy0AVTVb4ANR1eSJEmSJjLMHrfFST4OnNwevwhYPLqSJEmSNJFhgttrgdcBb2iPvw98ZGQVSZIkaULDBLfXVNUHgA+MNST5G+BDI6tKkiRJ9zHMOW4HT9D2smmuQ5IkSasx6R63JC8AXgjslOS0gUmbAteMujBJkiStaqpDpT8CVgBb0X0lyJgbgfNGWZQkSZLua9LgVlWXAJcAT525ciRJkjSZ1Z7jluQvk/w2yfVJbkhyY5Ibhlhu+yTfSXJBkvPbBQ0k2TLJma3PM5Ns0dqT5MNJliQ5L8mTBvo6uM3/2yQTnXMnSZK01hvm4oT/D/jzqtq8qjarqk2rarMhlrsTeFNV7QI8BXhdkl2AtwDfqqqdgW+1xwDPBHZut0OAj0IX9IC3A3sAuwNvHwt7kiRJ65JhgtsVVfXrNe24qlZU1c/a/RuBXwMLgAPpxj6l/XxOu38g8Mnq/ASYl2QbYF/gzKq6pqquBc4E9lvTeiRJkvpu2JETPgt8Gbh9rLGqvjjsSpIsBJ4I/BTYuqpWtEmXA1u3+wuAZQOLXdraJmuXJElapwwT3DYDbgH2GWgrYKjgluShwBeAQ6vqhiT3dlJVSWr4cqdczyF0h1jZYYcdpqNLSZKkOWW1wa2qXn5/O0+yIV1o+9TAHrorkmxTVSvaodArW/tyYPuBxbdrbcuBPce1f3eCOo8FjgVYtGjRtIRBSZKkuWSYq0ofneRbSX7VHv9RkrcNsVyA44BftyGzxpzGvaMxHAx8ZaD9pe3q0qcA17dDqmcA+yTZol2UsE9rkyRJWqcMc3HCx4DDgTsAquo84KAhlnsa8BJgryTnttv+wHuAZyT5LfD09hjgdOAiYElb5/9u67sGeBdwdru9s7VJkiStU4Y5x+3BVXXW4LlpdF/1MaWq+gGQSSbvPcH8Bbxukr6OB45ffamSJElrr2H2uF2V5JF0FySQ5Ll0Q2FJkiRpBg2zx+11dCf9PzbJcuBi4MUjrUqSJEn3McxVpRcBT0/yEGC99mW6kiRJmmGrDW5J5gEvBRYCG4yd61ZVbxhpZZIkSVrFMIdKTwd+AvwSuHu05UiSJGkywwS3TarqjSOvRJIkSVMa5qrSk5K8Ksk2SbYcu428MkmSJK1imD1uvwfeB/w97StB2s8/GFVRkiRJuq9hgtubgEdV1VWjLkaSJEmTG+ZQ6RLgllEXIkmSpKkNs8ftZuDcJN8Bbh9r9OtAJM1lX136vmnr64CFh01bX5L0QAwT3L7cbpIkSZpFw4yccGKSBwE7VNWFM1CTJEmSJrDac9ySHACcC3yjPd4tyWmjLkySJEmrGubihCOA3YHrAKrqXPwqEEmSpBk3THC7o6quH9fm0FeSJEkzbJiLE85P8kJg/SQ7A28AfjTasiRJkjTeMHvc/g+wK91XgXwGuAE4dJRFSZIk6b6Guar0Frrhrv5+9OVIkiRpMqsNbkkWAW8FFg7OX1V/NLqyJEmSNN4w57h9CjgM+CVelCBJkjRrhgluK6vK722TJEmaZcMEt7cn+TjwLVYdq/SLI6tKkiRJ9zFMcHs58FhgQ+49VFqAwU2SJGkGDRPcnlxVjxl5JZIkSZrSMN/j9qMku4y8EkmSJE1pmD1uTwHOTXIx3TluAcqvA5EkSZpZwwS3/UZehSRJklZrmJETLpmJQiRJkjS1Yc5xkyRJ0hxgcJMkSeoJg5skSVJPGNwkSZJ6wuAmSZLUEwY3SZKknjC4SZIk9YTBTZIkqScMbpIkST1hcJMkSeoJg5skSVJPGNwkSZJ6wuAmSZLUEwY3SZKknjC4SZIk9YTBTZIkqScMbpIkST1hcJMkSeoJg5skSVJPGNwkSZJ6wuAmSZLUEwY3SZKknhhZcEtyfJIrk/xqoO2IJMuTnNtu+w9MOzzJkiQXJtl3oH2/1rYkyVtGVa8kSdJcN8o9bicA+03QfkxV7dZupwMk2QU4CNi1LfOvSdZPsj7wEeCZwC7AC9q8kiRJ65wNRtVxVX0vycIhZz8QOKWqbgcuTrIE2L1NW1JVFwEkOaXNe8E0lytJkjTnjSy4TeH1SV4KLAbeVFXXAguAnwzMc2lrA1g2rn2PiTpNcghwCMAOO+ww3TVL66SvLn3ftPV1wMLDpq0vSVpXzfTFCR8FHgnsBqwAjp6ujqvq2KpaVFWL5s+fP13dSpIkzRkzusetqq4Yu5/kY8DX2sPlwPYDs27X2piiXZIkaZ0yo3vckmwz8PAvgLErTk8DDkqycZKdgJ2Bs4CzgZ2T7JRkI7oLGE6byZolSZLmipHtcUvyGWBPYKsklwJvB/ZMshtQwFLg1QBVdX6SU+kuOrgTeF1V3dX6eT1wBrA+cHxVnT+qmiVJkuayUV5V+oIJmo+bYv6jgKMmaD8dOH0aS5MkSeolR06QJEnqCYObJElSTxjcJEmSesLgJkmS1BMGN0mSpJ4wuEmSJPWEwU2SJKknDG6SJEk9YXCTJEnqCYObJElSTxjcJEmSesLgJkmS1BMGN0mSpJ4wuEmSJPWEwU2SJKknDG6SJEk9YXCTJEnqCYObJElSTxjcJEmSesLgJkmS1BMGN0mSpJ4wuEmSJPWEwU2SJKknDG6SJEk9YXCTJEnqCYObJElSTxjcJEmSesLgJkmS1BMGN0mSpJ4wuEmSJPWEwU2SJKknDG6SJEk9YXCTJEnqCYObJElSTxjcJEmSesLgJkmS1BMGN0mSpJ4wuEmSJPWEwU2SJKknDG6SJEk9YXCTJEnqCYObJElSTxjcJEmSesLgJkmS1BMGN0mSpJ4wuEmSJPWEwU2SJKknDG6SJEk9YXCTJEnqCYObJElST4wsuCU5PsmVSX410LZlkjOT/Lb93KK1J8mHkyxJcl6SJw0sc3Cb/7dJDh5VvZIkSXPdKPe4nQDsN67tLcC3qmpn4FvtMcAzgZ3b7RDgo9AFPeDtwB7A7sDbx8KeJEnSumZkwa2qvgdcM675QODEdv9E4DkD7Z+szk+AeUm2AfYFzqyqa6rqWuBM7hsGJUmS1gkzfY7b1lW1ot2/HNi63V8ALBuY79LWNln7fSQ5JMniJItXrlw5vVVLkiTNAbN2cUJVFVDT2N+xVbWoqhbNnz9/urqVJEmaM2Y6uF3RDoHSfl7Z2pcD2w/Mt11rm6xdkiRpnTPTwe00YOzK0IOBrwy0v7RdXfoU4Pp2SPUMYJ8kW7SLEvZpbZIkSeucDUbVcZLPAHsCWyW5lO7q0PcApyZ5BXAJ8Pw2++nA/sAS4Bbg5QBVdU2SdwFnt/neWVXjL3iQJElaJ4wsuFXVCyaZtPcE8xbwukn6OR44fhpLkyRJ6iVHTpAkSeoJg5skSVJPGNwkSZJ6wuAmSZLUEwY3SZKknjC4SZIk9YTBTZIkqScMbpIkST1hcJMkSeoJg5skSVJPGNwkSZJ6wuAmSZLUEwY3SZKknjC4SZIk9YTBTZIkqScMbpIkST1hcJMkSeoJg5skSVJPGNwkSZJ6wuAmSZLUEwY3SZKknjC4SZIk9YTBTZIkqScMbpIkST1hcJMkSeoJg5skSVJPGNwkSZJ6wuAmSZLUEwY3SZKknjC4SZIk9YTBTZIkqScMbpIkST1hcJMkSeoJg5skSVJPbDDbBUh6YL669H3T1tcBCw+btr4kSdPPPW6SJEk9YXCTJEnqCYObJElST3iOmzTA88UkSXOZe9wkSZJ6wuAmSZLUEwY3SZKknjC4SZIk9YTBTZIkqScMbpIkST1hcJMkSeoJg5skSVJPGNwkSZJ6wuAmSZLUEwY3SZKknpiV4JZkaZJfJjk3yeLWtmWSM5P8tv3corUnyYeTLElyXpInzUbNkiRJs20297j9WVXtVlWL2uO3AN+qqp2Bb7XHAM8Edm63Q4CPznilkiRJc8BcOlR6IHBiu38i8JyB9k9W5yfAvCTbzEaBkiRJs2m2glsB/5nknCSHtLatq2pFu385sHW7vwBYNrDspa1NkiRpnbLBLK33j6tqeZKHA2cm+e/BiVVVSWpNOmwB8BCAHXbYYfoqlSRJmiNmZY9bVS1vP68EvgTsDlwxdgi0/byyzb4c2H5g8e1a2/g+j62qRVW1aP78+aMsX5IkaVbMeHBL8pAkm47dB/YBfgWcBhzcZjsY+Eq7fxrw0nZ16VOA6wcOqUqSJK0zZuNQ6dbAl5KMrf/TVfWNJGcDpyZ5BXAJ8Pw2/+nA/sAS4Bbg5TNfsiRJ0uyb8eBWVRcBT5ig/Wpg7wnaC3jdDJQmSZI0p82lrwORJEnSFAxukiRJPWFwkyRJ6onZ+h63tcJXl75v2vo6YOFh09aXJElaO7nHTZIkqScMbpIkST1hcJMkSeoJg5skSVJPGNwkSZJ6wuAmSZLUEwY3SZKknjC4SZIk9YTBTZIkqScMbpIkST1hcJMkSeoJg5skSVJPGNwkSZJ6wuAmSZLUEwY3SZKknjC4SZIk9YTBTZIkqScMbpIkST1hcJMkSeoJg5skSVJPGNwkSZJ6wuAmSZLUEwY3SZKknjC4SZIk9YTBTZIkqScMbpIkST1hcJMkSeoJg5skSVJPGNwkSZJ6wuAmSZLUEwY3SZKknjC4SZIk9YTBTZIkqScMbpIkST1hcJMkSeoJg5skSVJPGNwkSZJ6wuAmSZLUEwY3SZKknjC4SZIk9YTBTZIkqSc2mO0CtHb56tL3TWt/Byw8bGT9j+9bkqS5zj1ukiRJPWFwkyRJ6gmDmyRJUk8Y3CRJknrC4CZJktQTvQluSfZLcmGSJUneMtv1SJIkzbReBLck6wMfAZ4J7AK8IMkus1uVJEnSzOpFcAN2B5ZU1UVV9XvgFODAWa5JkiRpRqWqZruG1UryXGC/qnple/wSYI+qev3APIcAh7SHjwEuXINVbAVcNU3lri19j7p/a5+5fmeif/te+/q377Wn/z7WPBN9j7L/Ne13x6qaP8yMa83ICVV1LHDs/Vk2yeKqWjTNJfW671H3b+0z1+9M9G/fa1//9r329N/Hmmei71H2P8q6+3KodDmw/cDj7VqbJEnSOqMvwe1sYOckOyXZCDgIOG2Wa5IkSZpRvThUWlV3Jnk9cAawPnB8VZ0/jau4X4dY1/K+R92/tc9cvzPRv32vff3b99rTfx9rnom+R9n/yOruxcUJkiRJ6s+hUkmSpHWewU2aQUnSx74lTZ9R/K6O+vffvy9zxzoR3JLMG7jfq1+YPv+yWPuE7jmvdATrmNf67cW5q2uLUf598W/LxGai9iQj+3ysfp6j9FC4ZySjaZVkwXT3OdD37kk2G1Hff57kkaPoeyprdXBL8swk/wV8JMnhMLJfmFFux03G7vTwD+1Gs13AAzDdH8D7JTkDeH+Sv4Dpey8m2bz1/Y3W753T0e+4dTxmlB9kSfZK8ogR9f3CJE9o96ftdZ2hvy/+bZnYSP62tA/iN46i79b/s5J8OsnbkzxqmvrcL8lXgHclme7vf0uShyf5LvBxgKq6axr7f3qSc4DXTFefA33/aZIL6L6Yf1qDW6v7x8BxwDbT2fcw1trglmR34AjgaLqrO56U5PHTvI5nJfka3S/M06a5732S/Aj4lyQvgun9UEjynCT/nGTL6epzoO/9k3wD+FAb5WI6+35OkndNZ5/j+t+//RF8X5I9H2BfSbJRkvcD/0A33u6FwPOS7PzAq73HrcB1wOOTPK+te1r+K07yjCQ/BV7JCP5eJPmfSc4HXkb7j34a+356ku8DHwSeCNMalv9fe2ced1VV7vHv731BQFChRDRFQRFRHHC45IBIGSaaE2haiGLmmKhU93o1TUtvDl0b0Gua5azdNI3CrpoZijmkaAjifJ0qtVmcLmrw3D+etWNzOOe855y993nZtH6fz/6cPaz9W8951rOf/ay111Cof4m+pSZ3Ib5FUg9JpwAz8MrVKDNbmuNz1FvSpcCXgR8AGwPHShraIp8C51XA6XgA0Q84UtLaecgM/7CLxWHbWtKEkH/LviDlFy8B/hM428zOSF/PKDaSegMnAV81s8+a2e+ycge5+0mahev8dOBBYKNwvX3xlJmtkhswHfh62N8YX9+0D9ARzikj//bAQ8Be+Lxy3wWmhmsdGbkHBoPYH/goPmfdqTlxC5gIPAn8DpiUlTPF3QM4DZ93b09gMu6k9slB5k48eHgOeB/YNUdbEV6DvzCU6QTcwV6GL62Wlf9jQI+wPwq4OjnOgbsTGBTs/RPAa+n/lUEfPYGvAs8CEyuv5yj7lcCncy7LPsCNwN3Ax4FLgOOTPHPKpzD/En1LVe5CfEtFHvvjrZAnA7/OizfFfxIwOOyPAH4JrJeR84DEpoGxwKU5y9wBbAGch68P/kCO3FcBZ6Xy2SZH7k2Ay8N+n2CXA1N+OMvzeXBq/wTgxrxtpUsZ2p1hYX8ETgQuB44Kx1vhqytcFJzInGAoZ2ctuHD/KcCFKcP4KvAosFYW/uD8tgQuS53bAvgrsHZOso8CPhgc64+BDXMsh0OATcL+GngwNCkn7nGB8yjg7gJs6BhgWNj/EPBDYIcMtvjZivN7Ac/jL84LEgfQTHmmuD+T3Bfs7xdh/+d40LllVlvBW5TOTR3vigd0eQVuA8Iz2R8PnKcAw4DVcpB9v9T+oWR84bTTv0TfUpM7V98SyvQ84JPhuGfq2guECkX6fIv8B6XKUkCvcHwnsF0WmVPnPwn8Ca+snA2MySjzpNS5/sAt+Nqbt+CfNTfNwJ34vU2Au/BWt3nALLyS8vEM3AeG4w3xSv4YfP7XmcD1wDnN2nllOabOd+AViAuTMm3X1raMCv0T/pnlQbwmdg/+Wao//mL4BqFWBmwOPA6MbNEw0o57NPAMMCAcnwHMBr7WAvfhwPjU8RBgAfCB1LlLgR80a3Q1+Huk9m/Ea5irtaj7Su7VgkH3DMc/BKa0yL1cAJT+33jN+8iw31KtvkqZdoQtCRz+p1knUsUWT2NZMDgaGB72JwSHMiQj9ybAOimH9Bng78DccNzwSyelj6PD8bp4MHJlsMdZwDUpvTdrhwl/cv8H8YBnLPCTYIs3Alc2W66VZZk63wnsgvfPGdyinVTqPVf/UsUOo2+pzp2Lb8GDp+nAfcCBeAvhVGCdVJoDgN+3KHct/oGpNIPD9TUzcg4K18fhlYkewHHB3gfmIPMHgB2AM0O6LwJvA7Mqy7tJ7sQHTANuBTbDg/ETgz2unUHu5H1xId41ZXw43hyYD2yRYznuDDzVip1k2dqaWWF/Aq4FDgj7O+A11DPC8a3A1qmCuJzmazlTWd5xfwl/WV4U+O/FX27JZ5m+DfIOAH4EvBoMqjN17Rrg2oq0vwaGNiF3VX7c+SWtNbvgtZ7tKu6t68DrcafS9MZrOpu1UKaVOj+VUNsO1ycACwkvt5z4h1X8v7uAdTPa4lkEp1eRbghwHbBBBu6vAP+OO7xH8Na2eeH35kbKsY4+Tg862B+vqY4Iz89+wM9osiWlCv8ZeAvEecD/sqwW3g9vOWi4pbMK92nAxqnrW+GB/hot2kph/qWK7NG3FOxbwv0/BT4S9vfEA/ApFWlmA18M+x/LyP/NND+wN74CEHjr/qgWOQ+vkm4McAPQL6PM3wIOxtcG/wVekV2I+5dvN1KWdbhnsKyls18q3dgg++oZ5P52kHsw8B6wZyrtpTTxSbarcgznfwHs24odtrqVenBCqjPgb/D+PZjZXOB+YCNJW+D9CL4naXX8ZbQl/mmjGewOnG9mtwNfwJ3GYWY2DTge7wB5BN6Bs4+Zvd0IqZn9DX8INsdfvF9OXT4B2FPSv4Tjt4HHcENsCPX4LVicmd2Hv+wnSBoh6ej09RZlTzAA6G1mT0saLGlSo7JTXeeTU/nfhteAjpa0RtIpPyP/p1PXhwCLzOw1SRtI+mg9sjq2+CDwoSodzKcCqwN/6UrQOtwP4P2rxuCfXR4ys1FmtgcwTtLQrsoxhUp99AKOMbOZeAvcU4FrPj4Q4v0GeevxH4/bTV/CwAQzewvvLzYgA/dq+OdRAucC/Nk8pBmB2+Rfom9pTvYEDfmWys7oqTKdi3/6J+j+WWCkpM1SyY8DLpD0GlB1uoom+J8J/CPD9bWBxZKm4S3vg1vk3FzS8Aqx9sAHLP1fRpmfBrbBB/b8DnjYzEbiz9E4SetXlmUT3E8C20vaLDzzCcYD7+D23qrcT+EVrDfwZ/LzkkZKOoMaz2cL5TgipFsz5NesP8yEUgVuQfn/GMJuZkvD7n1Ah6Sx4fhxvHBGmNk3cAP8Ed6fY6KZ/bHB/Go57vuA4ZJ2NbOXzezOkG5vvPWgEe7EUK4xs9fx2vRESRuFfN7AW1TOkHQ4boAjgbeq8TXDb2G0VOr/fQtvcboHr+3XHX3TAHcyj9jGwBqSTsZrLgMbkLtekLJ+RQB0CnAu7nQbmkqiAf5dw/X1gc7gWH9WyS9pF6Xm7+nCFl/Ba9VIOkzS48BQ4DgzW8G5NsG9ELfzNYAvm9npKZoNzeyFDPq4DxgqaZeKYOFwvKXsb11xd8H/K9ye1wP+Dfi4pH0knY631DyZgftBvCzHhHTCX469u7DrZso0k3+JvqVl7mZ9SxFmEm4AAA6lSURBVJ/0QapMnwv3bxWO7wHWwp8lJI3CW09vxlsMr86JP0m/P95XbBjeIjQrA+ea8lGaUyTNxyudp1rtaTsa5Z+D6+OPwLFmdmZI/1dgFzP7fQbue/ApOhJ9HxL84kbAaan7snAPNbML8C8bn8N1fZCZVassN6vzpKL5Bt4iOagKZ2EoReAmaWtJvwLOwfvFJOcT+Z/FX2IHS+o0H/o7CP9uDnAk3tH0U2b2ap18mgkMXyG8zCWNlc/ntCneFNsId1IrXRx+HwZuA/4jleZi3PFtjxv0QWa2KA9+M1sSHOEg4GK85WCUmZ2Tvr9F7mQese2AnfAHZm8zW0E3Tb4sX2VZADQMd+ozccd6UQ29NBtgJQHaeGCfIPteZnZD4NtO0s+DvtZK5VPPFtfFAzXwFqujzexwM/tDhazNcv826GMjM3sv/cKs1TKTQd+TJD2GvzCPS8o+I/9vge3N7Br8uRmDdyr+RNBbFu5XCPMrBXtdB3i7WmtPi2XalH9p1Q4b9C2V3Hn7lqb4m/QtzXI35Fsk7SjpZnyOvT0UpvVIBX4P4X1B95DUw8yewCtryTxof8FHIh9kZq9U0Umr/KPD9WuB3c3spCQAysC5vZm9hz9Px5nZYdUqDy3wL8RtY1szWxz8i0I5vJWRu1LfL9WSvUXu9fD+ZwT/clLwua/mwJ2WG+AQM7uqUt9FohSBG14j/JGZHZAy8s6U83sT7wvSC5+DpyfelP4HADN7L9TeqiJDYJi8jF/EH/IDzOzPDXJLK877cjEwLARKgyQNM7NfAtOD0VVzIK3yD5TPIfRnYJqZ7VvFqLPI/kG8j8huZnZCpewZXpZDwvVFwAlmNrGGXloNsJKXyM14p9aTzOz3knpKugwf9TQDb8EZFzgbscU/A5jZPDO7v0LWLNz9CZ9bkxdmpS4y6jux8WfwWvdhlQFnBv518ICEYOenmtnROdnKuiyzFfC+SldU8GYt0y79Sw56f5HavqUWd16+pVX+RnxLFtm78i3j8ErdLXhr6KHAAEkdSeBnZs/hn8E2wfuJAryLBxCY2W/NP7GvgIz8z4frt5jZ7Jxlvtv883TeMr8Yri+pUfHJQ/YHzOzenLmfT3jMbIVPmXnoJKSpWoktEit14CapQ9LGwFtm9q1wbrx8iRmF43PwzoyL8A7PA3AnuwifL6sRtBoYJi/jl0PtpBluC7XSPpKSZteX8SH0C1jW3IvVn6m6Vf578Y79S8L5PLnn4K1Aj1c+jDm8LJMg5U9m9mylwDnw/zHwzzGzu1LUvcL/2tXMbsUf9s3ltbAlgf8rtGaLhXHnGHAuMLMHCuD/U8JVGXTmZSuBu1r/rTLofQXf0gB3Jt+SA39N35IDd03fksLWeH+s6/HPZD3xd8jSkM85kr6P95+bAYyWz97/1yBPV8jC//M2craLv0h9r6xyN6Lz4mBtHAnRyAbsSJgyIRyviddKP4F/FrsDHxV1Kl6jvoHlRwN20ODosZB2Y8LonnBuPN6KkUzUdw5wEz6qbj18eoQH8clZa07m2SD32fjLIhmV9im8BnIBXUzjUCR/wdz98EEGfcLxVLwvSXoaga+0ovO8+dO2CMuPnsI/j12aXMOdwA0sP/K1pi0WyV1WfbeDe1XQe4PcZ9K6bymMvwhuVnxnjMJfrmfiraJ3A1fgIw13ZsV3Rj+gfx2Zc+cvo8yRu77O27l1uwAppfTHO4G/ibf09E1dOw2fgHLfcJzM+7RTKk1Dcz5VKbzcAsMcuHeE2kPyi+RvFzcFvCzz5q9li+H+ZGb8YfjDPqAy33q2WCR3WfXdDu6y6z0H7oZ9S978RXFXKdP0tBKj8ZfwpFQ+l5OaCqKrMi2Cv4wyR+58Vv/Ic+t2AVLKWR+ffG8qPlJwQura1nhkPDUcr47XSrdtVLFVCi+3wDAH7q5aNQrj7w5ucnpZFsVfzxaT+/CJLq8B9q+81qqd58BdSn23SfZS6j0H7pZ8Sx78bZC9qzKdRZgPEO8zeBNh/sGuyrQo/jLKHLnr67w7tm7t4yafGmE3SWua96H6Lj7b9mLgw5LWBzCz+cC/Ap+TL6B7KD6pZtLfqWqH7Ar0xVuNpoX9salrt+KtSMmiyHOB14IchM6K9fLIyl2vD1vR/G3nNsfS0An5xZBmt+Rairurcs2NvwFbTEZXKtzXK9ya6CIZbbWCzEVyF6WPbuDPnXsV0XtW7pZ8S078uXM3Uaa98Pn2jg+37o77sWS0aq1BPLnzl1HmyF1f592NtgducqwnaTY+J9Rk4DuS1jazxWb2Dj4T8QB8EWQAzOz7+KLCZ+Hr4H3WaneqT/IqLDAsOugsq+xFvyzz5G/FFs3M5J2o38afnx2T8xVyFsZdVn23g3tV0Hss00xlunu4/118frd+kubg/eROsOrTZOTOX0aZI3d9na9UsDY277Fs6ZLhwHXJOXx5l1sq0k7HBwasxfL9j7rqWCu8o+9sfLmV7+JL9qydSrMLvixG5dIVn8eHnt9BlfXMiuQus+xNch9axR6uA87KqUwb4s9gi6unzlddg7FI7rLqu03cpdV7LNNcy7Q/ywY/9CG1/Fk7+Msoc+Sur/OVbWtPJq7ArwHn403i+wBXp6534J/gdkud64dPEPkQ3gfiQ43k00LhNRQYFsldZtkzcDf6ssyVv0hbLJK7rPpuB3fZ9R7LNPcyfTiU6fr1dJI3fxlljtz1db6ybsVn4MqcB3wHOAqfh2dP4GVgdCrdscDs1PHB+Np5lwPrdJFHaV/GZZW9jHop0haL5C6rvtvEXVq9xzLttjLNnb+MMkfurmOLlXUrPgNfoHVK6vgSfPHeqcAj4VwHPtP5jcCQcG4/YGwD/KU1jLLKXla9FGmLBXOXUt9tkr2Ueo9l2j1lWhR/GWWO3PV1vjJvxWfgU3f0YlmT+mTg3LA/D18SBXztrx+0wF9awyir7GXVS5G2WDB3KfXdJtlLqfdYpt1TpkXxl1HmyF3erfBRpWb2jpm9a8uGdo9n2TI3R+BLzNyKjxh9FJaNLGoQjwA3KiwOiy/avKH5oq+dkqaZj1DaAFhiZi8GuX5iZnO6kbvMspdSL0XaYsF2Xkp9t0P2Eus9lmkNFP3OKIK/jDJH7vKiR7syCg+54Qso/zScfhOf5HVL4AUL62GaeZjcCMyH+KYxHpgf9o8AjgqFtxk+2ikZit5lHkVyl1n2MuslpC3EFoviLrO+i5Y9Qdn0Hsu0axT5nBbFX0aZI3cJYW1q2sOHjPcCrgUm4pO7Xg2smRN/J948fxthKSZ8Vu7+wBgyjBwpkrvMspdVL0XaYsHcpdR3m2Qvpd5jmXZPmRbFX0aZI3f5tvZm5hNbLgV+BRyZM3dpDaOsspdcL0XaYiHcJdd34c61jHqPZdo9ZVokfxlljtzl2tqbmfd5OBXoVRB/aQ2jrLKXVS9F2mLB3KXUd5tkL6XeY5l2T5kWxV9GmSN3uTaFP71KQNIGwBTgG+ZLWZSCu2j+snK3g79sKLO+y1yWZdZLmWWPiIhYEatU4BYRERERERERsSqj8OlAIiIiIiIiIiIi8kEM3CIiIiIiIiIiSoIYuEVERERERERElAQxcIuIiIiIiIiIKAli4BYREfFPC0lDJH06B47H88inMp2kHSTNyCJfRETEqoUYuEVERPwzYwiQKXDLOZ/l0pnZXDM7sSCZIiIiSogYuEVERLQFoTXpKUlXSXpG0vWSPibpPknPShotqa+kKyQ9JOk3kvYL906VNFPSnZJelHSCpM+HNA9K+kBIt4mk2yU9IuleSSPC+askzZB0v6TnJR0YxDoP2FXSPEnTJfWWdKWkBYH7IzX+y/aSHpP0GPC5iv94r6RHw7ZzjXw6JX1d0sOS5ks6pka6cWHdTySdJenqwP+SpImSLgiy3i6pZ0q2e4IO7pC0Xjh/oqQnQn7/nWPRRkREtBPdPQNw3OIWt3+ODW9N+juwFV5pfAS4Al86aT9gJvA14NCQvj/wDNAXmAo8B6wBDAQWAceGdN8ETg77dwGbhv0PA78M+1cBN4V8twCeC+fHAbemZPwCcEXYHwG8DPSu8l/mA2PD/teBx8P+6kl6YFNgbo18jgZOD/u9gLnA0Crp/nEMnIWvUNAT2AZ4B5gQrv0Y2D9cux8YGM4fnPo/rxBmlgf6d7c9xC1ucWtt61EnpouIiIjIGy+Y2QIASQuBu8zMJC3AA7sNgH0lfTGk7w1sGPZnm9mbwJuSFgGzwvkFwNaS+gE7AzdJSvLrlcp7ppktBZ6QNKiGfGOAiwDM7ClJLwHD8UCNIHd/PPCZE05dC0wI+z2BiyWNApaEe6thjyBz0vK3Fh7ovVcjfYLbzOz9oK9O4PZwPtHfZsCWwJ1BB53AqyHNfOB6STPxIDkiIqKEiIFbREREO5FeFmlp6ngp7o+WAJPM7On0TZI+3MC9HcDrZjaqgbxVI01VSLoS2BZvtarXV2068Ae8RawDWFyLEphmZndU5DOuC1HeBTCzpZLeN7Nk6ZtEBwIWmtlOVe7dGxgL7AN8SdJWZvb3LvKLiIhYyRD7uEVERKxMuAOYptBcJGnbRm80szeAFyQdFO6VpG26uO1N/PNrgnuByeH+4Xhr39NmdoSZjTKzvczsdeB1SWPCPZNT968FvBpa9qbgLV7V8rkDOC7VL224pL5V0jWLp4GBknYKvD0ljZTUAQw2s9nAKUHOfhnyiYiI6CbEwC0iImJlwtn458b54VPq2U3ePxk4MgwaWIj3nauH+cCSMNBgOnAJ0BE+Rf4QmGrVF08/AvgvSfNYvvXuEuDwkP8I4O0a+XwPeAJ4VD6VyGV4i1lluqZgZu8BBwLnBxnm4Z+PO4Hrwv/6DTAjBKARERElQ1xkPiIiIiIiIiKiJIgtbhERERERERERJUEM3CIiIiIiIiIiSoIYuEVERERERERElAQxcIuIiIiIiIiIKAli4BYRERERERERURLEwC0iIiIiIiIioiSIgVtEREREREREREkQA7eIiIiIiIiIiJLg/wG7JTuDGOtRSQAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<Figure size 720x720 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "years = mdates.YearLocator()\n",
    "months = mdates.MonthLocator()\n",
    "yearsFmt = mdates.DateFormatter('%Y-%m')\n",
    "\n",
    "fig, ax = plt.subplots()\n",
    "fig.set_size_inches(10, 10)\n",
    "\n",
    "ax.bar(x, y, width=25, color=\"#b2df8a\")\n",
    "\n",
    "ax.xaxis.set_major_locator(months)\n",
    "ax.xaxis.set_major_formatter(yearsFmt)\n",
    "# ax.xaxis.set_minor_locator(months)\n",
    "\n",
    "ax.set_xlabel(\"memento-datetimes\")\n",
    "ax.set_ylabel(\"memento count\")\n",
    "ax.set_title(\"Memento Count Per Month for Measure Summaries\\nfor measure summaries\\n at qualitymeasures.ahrq.gov\")\n",
    "\n",
    "fig.autofmt_xdate()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "datetime.datetime(2017, 5, 1, 0, 0)"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(monthbuckets.keys())[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1505"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "monthbuckets[list(monthbuckets.keys())[0]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "http://wayback.archive-it.org/all/20160930143938/https://www.qualitymeasures.ahrq.gov/summaries/summary/36635/Foreign-object-retention-percentage-of-unintentionally-retained-foreign-objects-during-labor-and-delivery\n",
      "http://wayback.archive-it.org/all/20160930143943/https://www.qualitymeasures.ahrq.gov/summaries/summary/36636/Foreign-object-retention-percentage-of-vaginal-deliveries-where-a-baseline-count-was-conducted\n",
      "http://wayback.archive-it.org/all/20160930143948/https://www.qualitymeasures.ahrq.gov/summaries/summary/36637/Foreign-object-retention-percentage-of-vaginal-deliveries-where-a-final-count-was-conducted\n",
      "http://wayback.archive-it.org/all/20160930143933/https://www.qualitymeasures.ahrq.gov/summaries/summary/36638/Foreign-object-retention-percentage-of-cases-where-final-counts-were-not-reconciled-with-baseline-counts-and-imaging-was-performed\n",
      "http://wayback.archive-it.org/all/20160930143802/https://www.qualitymeasures.ahrq.gov/summaries/summary/36652/Diagnosis-of-breast-disease-percentage-of-BIRADS-category-4-or-BIRADS-category-5-mammograms-that-are-followed-by-a-biopsy-within-7-to-10-days\n",
      "http://wayback.archive-it.org/all/20160930143913/https://www.qualitymeasures.ahrq.gov/summaries/summary/36725/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-patients-with-documentation-of-a-pressure-ulcer\n",
      "http://wayback.archive-it.org/all/20160930143928/https://www.qualitymeasures.ahrq.gov/summaries/summary/36726/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-patients-evaluated-for-pressure-ulcer-with-documentation-of-a-pressure-ulcer\n",
      "http://wayback.archive-it.org/all/20160930143842/https://www.qualitymeasures.ahrq.gov/summaries/summary/36727/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-patients-with-documentation-in-the-medical-record-indicating-a-risk-assessment-using-the-Braden-Scale-or-Braden-Q-was-completed-upon-admission\n",
      "http://wayback.archive-it.org/all/20160930143852/https://www.qualitymeasures.ahrq.gov/summaries/summary/36728/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-patients-with-documentation-in-the-medical-record-indicating-patient-risk-was-reassessed-daily-using-the-Braden-Scale-or-Braden-Q-or-as-indicated-for-care-setting\n",
      "http://wayback.archive-it.org/all/20160930143847/https://www.qualitymeasures.ahrq.gov/summaries/summary/36729/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-patients-with-documentation-in-the-medical-record-indicating-a-risk-assessment-was-done-using-specific-questions\n",
      "http://wayback.archive-it.org/all/20160930143858/https://www.qualitymeasures.ahrq.gov/summaries/summary/36730/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-patients-with-documentation-in-the-medical-record-that-a-headtotoe-reinspection-and-palpation-were-completed-every-8-to-24-hours-depending-on-the-status-of-the-patient\n",
      "http://wayback.archive-it.org/all/20160930143903/https://www.qualitymeasures.ahrq.gov/summaries/summary/36731/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-patients-with-documentation-in-the-medical-record-that-a-headtotoe-skin-inspection-and-palpation-were-completed-within-six-hours-of-admission\n",
      "http://wayback.archive-it.org/all/20160930143807/https://www.qualitymeasures.ahrq.gov/summaries/summary/36732/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-atrisk-patients-with-documentation-in-the-medical-record-that-a-headtotoe-skin-inspection-was-completed\n",
      "http://wayback.archive-it.org/all/20160930143918/https://www.qualitymeasures.ahrq.gov/summaries/summary/36733/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-patients-with-documentation-of-interventions-including-patient-education-in-the-medical-record\n",
      "http://wayback.archive-it.org/all/20160930143817/https://www.qualitymeasures.ahrq.gov/summaries/summary/36734/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-inpatients-with-pressure-ulcers-whose-medical-record-contains-documentation-of-a-comprehensive-patient-assessment-and-thorough-wound-evaluation\n",
      "http://wayback.archive-it.org/all/20160930143822/https://www.qualitymeasures.ahrq.gov/summaries/summary/36735/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-inpatients-with-pressure-ulcers-whose-medical-record-contains-documentation-of-a-partial-wound-assessment-with-every-dressing-change\n",
      "http://wayback.archive-it.org/all/20160930143832/https://www.qualitymeasures.ahrq.gov/summaries/summary/36736/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-outpatients-with-pressure-ulcers-whose-medical-record-contains-documentation-of-a-comprehensive-patient-assessment-and-thorough-wound-evaluation\n",
      "http://wayback.archive-it.org/all/20160930143923/https://www.qualitymeasures.ahrq.gov/summaries/summary/36737/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-patients-with-pressure-ulcers-whose-medical-record-contains-documentation-of-a-pressure-ulcer-treatment-plan-in-their-plan-of-care\n",
      "http://wayback.archive-it.org/all/20160930143827/https://www.qualitymeasures.ahrq.gov/summaries/summary/36738/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-outpatients-with-a-pressure-ulcers-with-documentation-in-the-medical-record-that-education-was-provided-to-patient-family-andor-caregiver-regarding-the-treatment-progression-and-prevention-of-press\n",
      "http://wayback.archive-it.org/all/20160930143812/https://www.qualitymeasures.ahrq.gov/summaries/summary/36739/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-inpatients-with-a-pressure-ulcer-who-are-discharged-home-with-documentation-in-the-medical-record-that-written-instructions-and-educational-materials-were-given-to-the-patient-andor-hisher-caregive\n",
      "http://wayback.archive-it.org/all/20160930143908/https://www.qualitymeasures.ahrq.gov/summaries/summary/36740/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-patients-with-documentation-in-the-medical-record-that-communication-of-a-transferdischarge-plan-for-patients-with-a-pressure-ulcers-took-place-addressing-skin-status-and-the-pressure-ulcer-prevent\n",
      "http://wayback.archive-it.org/all/20160930143837/https://www.qualitymeasures.ahrq.gov/summaries/summary/36741/Pressure-ulcer-prevention-and-treatment-protocol-percentage-of-patients-with-a-pressure-ulcer-who-are-transferreddischarged-with-documentation-in-the-medical-record-of-the-transferdischarge-plan\n",
      "http://wayback.archive-it.org/all/20160930144426/https://www.qualitymeasures.ahrq.gov/summaries/summary/36742/Adult-acute-and-subacute-low-back-pain-percentage-of-patients-with-low-back-pain-diagnosis-who-have-all-of-the-following-at-the-initial-visit-with-the-physician-pain-assessment-using-the-Visual-Analog-Scale-pain-diagram-or-other-assessment-tool-functional-stat\n",
      "http://wayback.archive-it.org/all/20160930144420/https://www.qualitymeasures.ahrq.gov/summaries/summary/36743/Adult-acute-and-subacute-low-back-pain-percentage-of-patients-with-low-back-pain-diagnosis-who-have-a-reassessment-at-each-followup-visit-that-includes-pain-assessment-using-the-Visual-Analog-Scale-pain-diagram-or-other-assessment-tool-functional-status-using-\n",
      "http://wayback.archive-it.org/all/20160930144406/https://www.qualitymeasures.ahrq.gov/summaries/summary/36744/Adult-acute-and-subacute-low-back-pain-percentage-of-patients-with-a-diagnosis-of-nonspecific-back-pain-for-whom-the-physician-ordered-imaging-studies-during-the-six-weeks-after-pain-onset-in-the-absence-of-red-flags\n",
      "http://wayback.archive-it.org/all/20160930144446/https://www.qualitymeasures.ahrq.gov/summaries/summary/36745/Adult-acute-and-subacute-low-back-pain-percentage-of-patients-with-nonspecific-back-pain-diagnosis-who-received-inappropriate-repeat-imaging-studies-in-the-absence-of-red-flags-or-progressive-symptoms\n",
      "http://wayback.archive-it.org/all/20160930144509/https://www.qualitymeasures.ahrq.gov/summaries/summary/36746/Adult-acute-and-subacute-low-back-pain-percentage-of-patients-with-radicular-pain-for-whom-the-clinician-ordered-imaging-studies-during-the-six-weeks-after-pain-onset\n",
      "http://wayback.archive-it.org/all/20160930144413/https://www.qualitymeasures.ahrq.gov/summaries/summary/36749/Adult-acute-and-subacute-low-back-pain-percentage-of-patients-with-low-back-pain-diagnosis-who-are-prescribed-opioids\n",
      "http://wayback.archive-it.org/all/20160930144432/https://www.qualitymeasures.ahrq.gov/summaries/summary/36750/Adult-acute-and-subacute-low-back-pain-percentage-of-patients-with-low-back-pain-diagnosis-who-have-their-functional-status-assessed-using-the-Oswestry-Disability-Questionnaire-or-other-assessment-tool\n",
      "http://wayback.archive-it.org/all/20160930144438/https://www.qualitymeasures.ahrq.gov/summaries/summary/36751/Adult-acute-and-subacute-low-back-pain-percentage-of-patients-with-low-back-pain-diagnosis-who-have-their-pain-status-assessed-using-the-Visual-Analog-Scale-pain-diagram-or-other-assessment-tool\n",
      "http://wayback.archive-it.org/all/20160930144454/https://www.qualitymeasures.ahrq.gov/summaries/summary/36752/Adult-acute-and-subacute-low-back-pain-percentage-of-patients-with-nonspecific-low-back-pain-diagnosis-who-have-had-collaborative-decisionmaking-with-regards-to-referral-to-a-specialist\n",
      "http://wayback.archive-it.org/all/20160930144501/https://www.qualitymeasures.ahrq.gov/summaries/summary/36753/Adult-acute-and-subacute-low-back-pain-percentage-of-patients-with-radicular-pain-diagnosis-who-have-had-collaborative-decisionmaking-with-regards-to-imaging-intervention-andor-surgery\n",
      "http://wayback.archive-it.org/all/20160930144002/https://www.qualitymeasures.ahrq.gov/summaries/summary/36852/Immunizations-percentage-of-patients-who-by-age-13-years-were-uptodate-with-the-following-recommended-adolescent-immunizations-one-human-papillomavirus-vaccine-HPV-for-females-one-meningococcal-MCV4-one-tetanus-diphtheria-toxoids-and-acellular-pertussis-vaccin\n",
      "http://wayback.archive-it.org/all/20160930143953/https://www.qualitymeasures.ahrq.gov/summaries/summary/36853/Immunizations-percentage-of-adult-patients-19-years-and-older-who-are-uptodate-with-the-following-immunizations-one-tetanus-diphtheria-toxoids-vaccine-Td-in-the-last-10-years-two-doses-of-varicella-or-history-of-disease-up-to-year-1995-pneumococcal-polysacchar\n",
      "http://wayback.archive-it.org/all/20160930143958/https://www.qualitymeasures.ahrq.gov/summaries/summary/36854/Immunizations-percentage-of-patients-or-parents-if-patient-younger-than-18-years-who-receive-education-regarding-the-importance-of-immunizations-and-recommended-immunization-schedules\n",
      "http://wayback.archive-it.org/all/20160930144016/https://www.qualitymeasures.ahrq.gov/summaries/summary/36944/Acute-care-prevention-of-falls-rate-of-inpatient-falls-per-1000-patient-days\n",
      "http://wayback.archive-it.org/all/20160930144027/https://www.qualitymeasures.ahrq.gov/summaries/summary/36945/Acute-care-prevention-of-falls-rate-of-inpatient-falls-with-injury-per-1000-patient-days\n",
      "http://wayback.archive-it.org/all/20160930144008/https://www.qualitymeasures.ahrq.gov/summaries/summary/36946/Acute-care-prevention-of-falls-percentage-of-patients-who-receive-appropriate-falls-prevention-interventions-based-upon-the-results-of-their-falls-risk-assessment\n",
      "http://wayback.archive-it.org/all/20160930144113/https://www.qualitymeasures.ahrq.gov/summaries/summary/38370/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-patients-initially-presenting-with-acute-symptoms-of-ischemic-stroke-within-three-hours-or-up-to-45-hours-for-patients-meeting-selected-criteria-of-stroke-onset-who-are-evaluated-by-a-clinician-within-10\n",
      "http://wayback.archive-it.org/all/20160930144105/https://www.qualitymeasures.ahrq.gov/summaries/summary/38371/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-patients-admitted-to-the-hospital-observation-unit-or-expedited-outpatient-TIA-clinic-with-documentation-of-clinical-TIA-symptoms-within-the-last-24-hours\n",
      "http://wayback.archive-it.org/all/20160930144038/https://www.qualitymeasures.ahrq.gov/summaries/summary/38372/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-eligible-patients-with-ischemic-stroke-treated-with-tPA\n",
      "http://wayback.archive-it.org/all/20160930144135/https://www.qualitymeasures.ahrq.gov/summaries/summary/38373/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-patients-who-are-not-candidates-for-tPA-treatment-who-receive-aspirin-within-24-hours-of-hospitalization-after-a-negative-head-CT-unless-contraindicated\n",
      "http://wayback.archive-it.org/all/20160930144032/https://www.qualitymeasures.ahrq.gov/summaries/summary/38374/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-eligible-patients-receiving-tPA-according-to-guideline\n",
      "http://wayback.archive-it.org/all/20160930144212/https://www.qualitymeasures.ahrq.gov/summaries/summary/38375/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-patients-with-stroke-symptoms-who-are-candidates-for-tPA-with-a-door-to-drug-time-time-of-arrival-to-time-of-drug-administration-of-less-than-60-minutes\n",
      "http://wayback.archive-it.org/all/20160930144217/https://www.qualitymeasures.ahrq.gov/summaries/summary/38376/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-patients-with-stroke-symptoms-who-undergo-a-CT-scan-within-25-minutes-of-arrival-in-the-emergency-department\n",
      "http://wayback.archive-it.org/all/20160930144222/https://www.qualitymeasures.ahrq.gov/summaries/summary/38377/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-tPA-nonrecipients-who-have-hypertension-appropriately-managed-in-the-first-48-hours-of-hospitalization-or-until-neurologically-stable\n",
      "http://wayback.archive-it.org/all/20160930144147/https://www.qualitymeasures.ahrq.gov/summaries/summary/38378/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-patients-who-receive-appropriate-intervention-for-hypoglycemia-and-hyperglycemia\n",
      "http://wayback.archive-it.org/all/20160930144140/https://www.qualitymeasures.ahrq.gov/summaries/summary/38379/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-patients-who-receive-appropriate-intervention-for-hyperthermia\n",
      "http://wayback.archive-it.org/all/20160930144157/https://www.qualitymeasures.ahrq.gov/summaries/summary/38380/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-patients-with-dehydration-who-receive-IV-fluids\n",
      "http://wayback.archive-it.org/all/20160930144206/https://www.qualitymeasures.ahrq.gov/summaries/summary/38381/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-patients-with-ischemic-stroke-with-paralysis-or-other-reason-for-immobility-receiving-appropriate-prevention-for-VTE-subcutaneous-heparin-or-pneumatic-compression-device\n",
      "http://wayback.archive-it.org/all/20160930144044/https://www.qualitymeasures.ahrq.gov/summaries/summary/38382/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-ischemic-stroke-patients-who-are-assessed-with-a-swallow-screening-test-before-receiving-food-fluids-or-medications-by-mouth\n",
      "http://wayback.archive-it.org/all/20160930144122/https://www.qualitymeasures.ahrq.gov/summaries/summary/38383/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-patients-mobilized-from-bed-within-24-hours-of-admission\n",
      "http://wayback.archive-it.org/all/20160930144128/https://www.qualitymeasures.ahrq.gov/summaries/summary/38384/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-patients-presenting-in-the-emergency-department-with-ischemic-stroke-for-whom-patientfamily-education-is-documented-in-the-medical-record\n",
      "http://wayback.archive-it.org/all/20160930144054/https://www.qualitymeasures.ahrq.gov/summaries/summary/38385/Diagnosis-and-treatment-of-ischemic-stroke-percentage-of-patients-admitted-to-a-hospital-unit-with-ischemic-stroke-for-whom-patientfamily-education-is-documented-in-the-medical-record\n",
      "http://wayback.archive-it.org/all/20160930144308/https://www.qualitymeasures.ahrq.gov/summaries/summary/38386/Diagnosis-and-management-of-asthma-percentage-of-patients-with-spirometry-or-peak-flow-at-the-last-visit-related-to-asthma\n",
      "http://wayback.archive-it.org/all/20160930144257/https://www.qualitymeasures.ahrq.gov/summaries/summary/38387/Diagnosis-and-management-of-asthma-percentage-of-patients-with-assessment-of-asthma-control-using-a-validated-questionnaire-at-the-last-visit-related-to-asthma\n",
      "http://wayback.archive-it.org/all/20160930144233/https://www.qualitymeasures.ahrq.gov/summaries/summary/38388/Diagnosis-and-management-of-asthma-percentage-of-hospitalized-patients-with-asthma-who-are-discharged-on-an-inhaled-antiinflammatory-medication\n",
      "http://wayback.archive-it.org/all/20160930144227/https://www.qualitymeasures.ahrq.gov/summaries/summary/38389/Diagnosis-and-management-of-asthma-percentage-of-discharged-patients-with-asthma-who-are-readmitted-to-hospital-within-30-days-of-discharge\n",
      "http://wayback.archive-it.org/all/20160930144303/https://www.qualitymeasures.ahrq.gov/summaries/summary/38390/Diagnosis-and-management-of-asthma-percentage-of-patients-with-asthma-who-return-to-the-emergency-department-for-treatment-of-asthma-within-30-days-of-last-visit-to-the-emergency-department\n",
      "http://wayback.archive-it.org/all/20160930144252/https://www.qualitymeasures.ahrq.gov/summaries/summary/38391/Diagnosis-and-management-of-asthma-percentage-of-patients-with-an-emergency-department-visit-or-inpatient-admission-for-an-asthma-exacerbation-who-are-discharged-from-the-emergency-department-or-inpatient-setting-with-an-asthma-discharge-plan\n",
      "http://wayback.archive-it.org/all/20160930144246/https://www.qualitymeasures.ahrq.gov/summaries/summary/38392/Diagnosis-and-management-of-asthma-percentage-of-patients-whose-asthma-is-not-controlled-or-have-change-in-medication-or-clinical-status-who-are-seen-by-a-health-care-clinician-within-two-to-six-weeks\n",
      "http://wayback.archive-it.org/all/20160930144239/https://www.qualitymeasures.ahrq.gov/summaries/summary/38393/Diagnosis-and-management-of-asthma-percentage-of-patients-whose-asthma-is-controlled-who-are-seen-by-a-health-care-clinician-every-one-to-six-months\n",
      "http://wayback.archive-it.org/all/20160930144332/https://www.qualitymeasures.ahrq.gov/summaries/summary/38394/Routine-prenatal-care-percentage-of-pregnant-patients-who-have-an-initial-risk-assessment-completed-within-two-visits-of-initiation-of-prenatal-care\n",
      "http://wayback.archive-it.org/all/20160930144321/https://www.qualitymeasures.ahrq.gov/summaries/summary/38395/Routine-prenatal-care-percentage-of-patients-planning-pregnancy-who-have-preconception-risk-assessmentcounseling\n",
      "http://wayback.archive-it.org/all/20160930144315/https://www.qualitymeasures.ahrq.gov/summaries/summary/38396/Routine-prenatal-care-percentage-of-patients-planning-a-pregnancy-who-receive-counseling-and-education-before-pregnancy-according-to-the-guideline\n",
      "http://wayback.archive-it.org/all/20160930144346/https://www.qualitymeasures.ahrq.gov/summaries/summary/38397/Routine-prenatal-care-percentage-of-pregnant-patients-who-receive-counseling-and-education-at-each-visit-as-outlined-in-the-guideline\n",
      "http://wayback.archive-it.org/all/20160930144338/https://www.qualitymeasures.ahrq.gov/summaries/summary/38398/Routine-prenatal-care-percentage-of-pregnant-patients-who-receive-counseling-about-aneuploidy-screening-in-the-first-trimester\n",
      "http://wayback.archive-it.org/all/20160930144352/https://www.qualitymeasures.ahrq.gov/summaries/summary/38399/Routine-prenatal-care-percentage-of-VBACeligible-pregnant-patients-who-have-a-collaborative-conversation-with-their-clinician-about-the-risks-and-benefits-of-VBAC\n",
      "http://wayback.archive-it.org/all/20160930144326/https://www.qualitymeasures.ahrq.gov/summaries/summary/38400/Routine-prenatal-care-percentage-of-patients-who-have-had-identified-preterm-birth-PTB-modifiable-risk-factors-who-receive-an-intervention\n",
      "http://wayback.archive-it.org/all/20160930144552/https://www.qualitymeasures.ahrq.gov/summaries/summary/39356/Venous-thromboembolism-VTE-prophylaxis-percentage-of-adult-hospitalized-patients-who-have-a-VTE-risk-assessment-within-24-hours-of-admission\n",
      "http://wayback.archive-it.org/all/20160930144643/https://www.qualitymeasures.ahrq.gov/summaries/summary/39357/Venous-thromboembolism-VTE-prophylaxis-percentage-of-hospitalized-patients-who-are-evaluated-for-VTE-prophylaxis-upon-referral-or-transfer-to-another-setting-service-practitioner-or-level-of-care-within-or-outside-the-organization\n",
      "http://wayback.archive-it.org/all/20160930144613/https://www.qualitymeasures.ahrq.gov/summaries/summary/39358/Venous-thromboembolism-VTE-prophylaxis-percentage-of-hospitalized-patients-at-risk-for-VTE-who-have-VTE-education-within-24-hours-of-admission-that-includes-1-VTE-risk-2-signs-and-symptoms-3-early-and-frequent-mobilization-and-4-clinically-appropriate-treatmen\n",
      "http://wayback.archive-it.org/all/20160930144701/https://www.qualitymeasures.ahrq.gov/summaries/summary/39359/Venous-thromboembolism-VTE-prophylaxis-percentage-of-hospitalized-patients-who-have-a-baseline-international-normalized-ratio-when-initially-prescribed-warfarin\n",
      "http://wayback.archive-it.org/all/20160930144636/https://www.qualitymeasures.ahrq.gov/summaries/summary/39360/Venous-thromboembolism-VTE-prophylaxis-percentage-of-hospitalized-patients-on-warfarin-for-whom-current-international-normalized-ratio-is-used-to-monitor-and-adjust-therapy\n",
      "http://wayback.archive-it.org/all/20160930144619/https://www.qualitymeasures.ahrq.gov/summaries/summary/39361/Venous-thromboembolism-VTE-prophylaxis-percentage-of-hospitalized-patients-on-prescribed-heparin-or-lowmolecularweight-heparin-who-have-appropriate-baseline-laboratory-tests-documented\n",
      "http://wayback.archive-it.org/all/20160930144537/https://www.qualitymeasures.ahrq.gov/summaries/summary/39362/Venous-thromboembolism-VTE-prophylaxis-percentage-of-adult-hospitalized-patients-on-prescribed-heparin-or-lowmolecularweight-heparin-who-have-appropriate-ongoing-laboratory-tests-drawn-and-used-to-adjust-therapy\n",
      "http://wayback.archive-it.org/all/20160930144544/https://www.qualitymeasures.ahrq.gov/summaries/summary/39363/Venous-thromboembolism-VTE-prophylaxis-percentage-of-adult-hospitalized-patients-receiving-heparin-therapy-for-VTE-prophylaxis-who-have-a-baseline-platelet-count-before-starting-heparin-and-then-a-platelet-count-every-other-day-over-the-course-of-14-days\n",
      "http://wayback.archive-it.org/all/20160930144558/https://www.qualitymeasures.ahrq.gov/summaries/summary/39364/Venous-thromboembolism-VTE-prophylaxis-percentage-of-adult-hospitalized-patients-with-creatinine-clearance-less-than-30-mLmin-in-the-medical-record-who-receive-a-reduced-dose-of-anticoagulation-therapy\n",
      "http://wayback.archive-it.org/all/20160930144605/https://www.qualitymeasures.ahrq.gov/summaries/summary/39365/Venous-thromboembolism-VTE-prophylaxis-percentage-of-discharged-patients-who-are-readmitted-to-the-hospital-with-VTE-within-30-days-of-discharge\n",
      "http://wayback.archive-it.org/all/20160930144517/https://www.qualitymeasures.ahrq.gov/summaries/summary/39388/Diagnosis-and-treatment-of-chest-pain-and-acute-coronary-syndrome-ACS-percentage-of-AMI-patients-who-receive-a-statin-agent-within-24-hours-of-arrival-and-at-discharge-from-hospital-for-whom-treatment-is-appropriate\n",
      "http://wayback.archive-it.org/all/20160930144523/https://www.qualitymeasures.ahrq.gov/summaries/summary/39389/Diagnosis-and-treatment-of-chest-pain-and-acute-coronary-syndrome-ACS-percentage-of-patients-with-AMI-who-are-referred-to-an-appropriate-cardiac-rehabilitation-program-postdischarge\n",
      "http://wayback.archive-it.org/all/20160930144530/https://www.qualitymeasures.ahrq.gov/summaries/summary/39390/Diagnosis-and-treatment-of-chest-pain-and-acute-coronary-syndrome-ACS-percentage-of-patients-with-AMI-with-referral-to-an-appropriate-cardiac-rehabilitation-program-Phase-2-or-Phase-3-postdischarge-who-enroll-in-the-program\n",
      "http://wayback.archive-it.org/all/20160930144358/https://www.qualitymeasures.ahrq.gov/summaries/summary/39391/Adult-acute-and-subacute-low-back-pain-percentage-of-patients-who-were-advised-on-maintenance-or-resumption-of-activities-against-bed-rest-use-of-heat-education-on-importance-of-active-lifestyle-and-exercise-and-recommendation-to-take-antiinflammatory-or-analg\n",
      "http://wayback.archive-it.org/all/20160930145029/https://www.qualitymeasures.ahrq.gov/summaries/summary/39410/Venous-thromboembolism-VTE-diagnosis-and-treatment-percentage-of-patients-with-VTE-treated-with-LMWH-who-receive-heparin-treatment-for-at-least-five-days-after-the-initiation-of-warfarin-therapy-and-until-INR-is-greater-than-or-equal-to-20-for-two-consecutive-\n",
      "http://wayback.archive-it.org/all/20160930145036/https://www.qualitymeasures.ahrq.gov/summaries/summary/39411/Venous-thromboembolism-VTE-diagnosis-and-treatment-percentage-of-patients-with-VTE-treated-with-UFH-who-receive-heparin-treatment-for-at-least-five-days-after-the-initiation-of-warfarin-therapy-and-until-INR-is-greater-than-or-equal-to-20-for-two-consecutive-d\n",
      "http://wayback.archive-it.org/all/20160930144945/https://www.qualitymeasures.ahrq.gov/summaries/summary/39412/Venous-thromboembolism-VTE-diagnosis-and-treatment-percentage-of-adult-patients-with-DVT-who-have-been-assessed-for-the-need-for-graduated-compression-stockings-not-TEDsTM\n",
      "http://wayback.archive-it.org/all/20160930145107/https://www.qualitymeasures.ahrq.gov/summaries/summary/39413/Venous-thromboembolism-VTE-diagnosis-and-treatment-percentage-of-patients-with-VTE-who-develop-PE\n",
      "http://wayback.archive-it.org/all/20160930145122/https://www.qualitymeasures.ahrq.gov/summaries/summary/39414/Venous-thromboembolism-VTE-diagnosis-and-treatment-percentage-of-VTE-patients-who-have-a-high-clinical-pretest-probability-CPTP-score-greater-than-6-for-PE-who-received-anticoagulation-prior-to-diagnostic-evaluation\n",
      "http://wayback.archive-it.org/all/20160930144954/https://www.qualitymeasures.ahrq.gov/summaries/summary/39415/Venous-thromboembolism-VTE-diagnosis-and-treatment-percentage-of-hospitalized-patients-with-VTE-who-receive-warfarin-on-day-one-of-heparin-therapy\n",
      "http://wayback.archive-it.org/all/20160930145043/https://www.qualitymeasures.ahrq.gov/summaries/summary/39416/Venous-thromboembolism-VTE-diagnosis-and-treatment-percentage-of-patients-with-VTE-who-are-initially-prescribed-warfarin-therapy-with-documentation-in-the-medical-record-indicating-a-baseline-INR-was-obtained\n",
      "http://wayback.archive-it.org/all/20160930145114/https://www.qualitymeasures.ahrq.gov/summaries/summary/39417/Venous-thromboembolism-VTE-diagnosis-and-treatment-percentage-of-patients-with-VTE-who-receive-ongoing-warfarin-therapy-with-documentation-in-the-medical-record-indicating-a-current-INR-is-available-and-is-used-to-monitor-and-adjust-therapy\n",
      "http://wayback.archive-it.org/all/20160930145100/https://www.qualitymeasures.ahrq.gov/summaries/summary/39418/Venous-thromboembolism-VTE-diagnosis-and-treatment-percentage-of-patients-with-VTE-who-are-prescribed-UFH-andor-LMWH-who-have-baseline-laboratory-tests-documented-in-their-medical-record\n",
      "http://wayback.archive-it.org/all/20160930145049/https://www.qualitymeasures.ahrq.gov/summaries/summary/39419/Venous-thromboembolism-VTE-diagnosis-and-treatment-percentage-of-patients-with-VTE-who-are-prescribed-UFH-and-LMWH-who-have-appropriate-laboratory-tests-platelets-PTT-for-those-on-UFH-available-to-monitor-and-adjust-therapy\n",
      "http://wayback.archive-it.org/all/20160930145023/https://www.qualitymeasures.ahrq.gov/summaries/summary/39420/Venous-thromboembolism-VTE-diagnosis-and-treatment-percentage-of-patients-with-suspected-VTE-who-have-a-clinical-pretest-probability-CPTP-assessment-completed\n",
      "http://wayback.archive-it.org/all/20160930145008/https://www.qualitymeasures.ahrq.gov/summaries/summary/39421/Venous-thromboembolism-VTE-diagnosis-and-treatment-percentage-of-patients-suspected-of-DVT-who-have-leg-duplex-ultrasound-DUS-performed-despite-a-low-clinical-pretest-probability-CPTP-and-a-negative-Ddimer-test\n",
      "http://wayback.archive-it.org/all/20160930145000/https://www.qualitymeasures.ahrq.gov/summaries/summary/39422/Venous-thromboembolism-VTE-diagnosis-and-treatment-percentage-of-patients-diagnosed-with-lower-extremity-VTE-who-meet-the-criteria-for-LMWH-and-for-whom-shared-decisionmaking-was-used-prior-to-implementing-therapy\n",
      "http://wayback.archive-it.org/all/20160930145016/https://www.qualitymeasures.ahrq.gov/summaries/summary/39423/Venous-thromboembolism-VTE-diagnosis-and-treatment-percentage-of-patients-with-any-of-these-diagnosis---VTE-PE-DVT---indicating-a-complete-list-of-medications-was-communicated-to-the-next-clinician-of-service-when-the-patient-is-referred-or-transferred-to-anot\n",
      "http://wayback.archive-it.org/all/20160930144734/https://www.qualitymeasures.ahrq.gov/summaries/summary/39531/NonOR-procedural-safety-percentage-of-wrong-invasive-or-highrisk-procedure-events-outside-of-the-operating-room-per-month\n",
      "http://wayback.archive-it.org/all/20160930144728/https://www.qualitymeasures.ahrq.gov/summaries/summary/39532/NonOR-procedural-safety-percentage-of-invasive-or-highrisk-procedures-outside-of-the-operating-room-that-met-observational-compliance\n",
      "http://wayback.archive-it.org/all/20160930144743/https://www.qualitymeasures.ahrq.gov/summaries/summary/43818/Diagnosis-and-treatment-of-headache-percentage-of-patients-diagnosed-with-primary-headache-using-the-appropriate-diagnostic-criteria\n",
      "http://wayback.archive-it.org/all/20160930144751/https://www.qualitymeasures.ahrq.gov/summaries/summary/43819/Diagnosis-and-treatment-of-headache-percentage-of-patients-with-a-primary-headache-who-received-educational-materials-on-headache\n",
      "http://wayback.archive-it.org/all/20160930144818/https://www.qualitymeasures.ahrq.gov/summaries/summary/43820/Diagnosis-and-treatment-of-headache-percentage-of-patients-with-migraine-headache-who-are-showing-improvement-in-functional-status-shown-by-using-one-of-the-following-diseasespecific-tools-or-questionnaires-eg-MIDAS-Headache-Impact-Test-HIT-Migraine-Specific-Q\n",
      "http://wayback.archive-it.org/all/20160930144842/https://www.qualitymeasures.ahrq.gov/summaries/summary/43821/Diagnosis-and-treatment-of-headache-percentage-of-patients-with-primary-headache-syndrome-who-are-prescribed-prophylactic-treatment-when-appropriate\n",
      "http://wayback.archive-it.org/all/20160930144812/https://www.qualitymeasures.ahrq.gov/summaries/summary/43822/Diagnosis-and-treatment-of-headache-percentage-of-patients-with-migraine-headache-seen-for-migraine-in-the-emergency-departmenturgent-care\n",
      "http://wayback.archive-it.org/all/20160930144758/https://www.qualitymeasures.ahrq.gov/summaries/summary/43823/Diagnosis-and-treatment-of-headache-percentage-of-patients-with-decreased-migraine-headache-shown-by-using-a-calendar-or-diary\n",
      "http://wayback.archive-it.org/all/20160930144836/https://www.qualitymeasures.ahrq.gov/summaries/summary/43824/Diagnosis-and-treatment-of-headache-percentage-of-patients-with-migraine-headache-with-treatment-plans\n",
      "http://wayback.archive-it.org/all/20160930144830/https://www.qualitymeasures.ahrq.gov/summaries/summary/43825/Diagnosis-and-treatment-of-headache-percentage-of-patients-with-migraine-headache-with-a-treatment-plan-who-report-adherence-to-their-treatment-plan\n",
      "http://wayback.archive-it.org/all/20160930144824/https://www.qualitymeasures.ahrq.gov/summaries/summary/43826/Diagnosis-and-treatment-of-headache-percentage-of-patients-with-migraine-headache-with-a-prescription-for-opiates-or-barbiturates-for-the-treatment-of-migraine\n",
      "http://wayback.archive-it.org/all/20160930144806/https://www.qualitymeasures.ahrq.gov/summaries/summary/43827/Diagnosis-and-treatment-of-headache-percentage-of-patients-with-migraine-headache-prescribed-appropriate-acute-treatment\n",
      "http://wayback.archive-it.org/all/20160930144854/https://www.qualitymeasures.ahrq.gov/summaries/summary/43828/Diagnosis-and-treatment-of-respiratory-illness-in-children-and-adults-percentage-of-patients-diagnosed-with-a-viral-upperrespiratory-infection-who-do-not-receive-an-antibiotic\n",
      "http://wayback.archive-it.org/all/20160930144848/https://www.qualitymeasures.ahrq.gov/summaries/summary/43829/Diagnosis-and-treatment-of-respiratory-illness-in-children-and-adults-percentage-of-patients-andor-parents-of-children-with-a-viral-upperrespiratory-infection-who-receive-home-treatment-education\n",
      "http://wayback.archive-it.org/all/20160930144925/https://www.qualitymeasures.ahrq.gov/summaries/summary/43830/Diagnosis-and-treatment-of-respiratory-illness-in-children-and-adults-percentage-of-patients-diagnosed-with-strep-pharyngitis-who-had-a-rapid-group-A-strep-test-or-strep-culture\n",
      "http://wayback.archive-it.org/all/20160930144919/https://www.qualitymeasures.ahrq.gov/summaries/summary/43831/Diagnosis-and-treatment-of-respiratory-illness-in-children-and-adults-percentage-of-patients-diagnosed-with-strep-pharyngitis-prescribed-firstline-medications-for-strep-pharyngitis\n",
      "http://wayback.archive-it.org/all/20160930144931/https://www.qualitymeasures.ahrq.gov/summaries/summary/43832/Diagnosis-and-treatment-of-respiratory-illness-in-children-and-adults-percentage-of-patients-diagnosed-with-strep-pharyngitis-and-prescribed-antibiotics-who-had-a-negative-culture-or-no-rapid-group-A-strep-test-or-strep-culture\n",
      "http://wayback.archive-it.org/all/20160930144937/https://www.qualitymeasures.ahrq.gov/summaries/summary/43833/Diagnosis-and-treatment-of-respiratory-illness-in-children-and-adults-percentage-of-patients-with-strep-pharyngitis-prescribed-antibiotics-with-documentation-of-education-on-24hour-treatment-prior-to-returning-to-work-school-or-day-care\n",
      "http://wayback.archive-it.org/all/20160930144913/https://www.qualitymeasures.ahrq.gov/summaries/summary/43834/Diagnosis-and-treatment-of-respiratory-illness-in-children-and-adults-percentage-of-patients-diagnosed-with-strep-pharyngitis-prescribed-antibiotics-with-documentation-of-being-educated-on-taking-the-complete-course\n",
      "http://wayback.archive-it.org/all/20160930144908/https://www.qualitymeasures.ahrq.gov/summaries/summary/43835/Diagnosis-and-treatment-of-respiratory-illness-in-children-and-adults-percentage-of-patients-diagnosed-with-strep-pharyngitis-instructed-on-actions-to-take-if-symptoms-worsen\n",
      "http://wayback.archive-it.org/all/20160930144902/https://www.qualitymeasures.ahrq.gov/summaries/summary/43836/Diagnosis-and-treatment-of-respiratory-illness-in-children-and-adults-percentage-of-patients-diagnosed-with-seasonal-allergic-rhinitis-being-treated-with-injectable-corticosteroids\n",
      "http://wayback.archive-it.org/all/20160930145152/https://www.qualitymeasures.ahrq.gov/summaries/summary/45140/Management-of-labor-percentage-of-patients-with-preterm-labor-who-received-antenatal-corticosteroids-prior-to-delivery\n",
      "http://wayback.archive-it.org/all/20160930145158/https://www.qualitymeasures.ahrq.gov/summaries/summary/45141/Management-of-labor-percentage-of-patients-with-protracted-labor-who-are-administered-oxytocin\n",
      "http://wayback.archive-it.org/all/20160930145128/https://www.qualitymeasures.ahrq.gov/summaries/summary/45142/Management-of-labor-percentage-of-patients-who-are-assessed-for-risk-status-on-entry-to-labor-and-delivery\n",
      "http://wayback.archive-it.org/all/20160930145139/https://www.qualitymeasures.ahrq.gov/summaries/summary/45144/Management-of-labor-percentage-of-patients-whose-oxytocin-is-discontinued\n",
      "http://wayback.archive-it.org/all/20160930145133/https://www.qualitymeasures.ahrq.gov/summaries/summary/45145/Management-of-labor-percentage-of-patients-who-have-an-IV-fluid-bolus-administered\n",
      "http://wayback.archive-it.org/all/20160930145145/https://www.qualitymeasures.ahrq.gov/summaries/summary/45146/Management-of-labor-percentage-of-patients-whose-position-is-changed-to-the-left-or-right-side-to-decrease-compression-of-vena-cava\n",
      "http://wayback.archive-it.org/all/20160930145430/https://www.qualitymeasures.ahrq.gov/summaries/summary/46813/Stable-coronary-artery-disease-percentage-of-patients-with-stable-coronary-artery-disease-who-are-prescribed-aspirin-and-antiatherosclerotic-medications\n",
      "http://wayback.archive-it.org/all/20160930145452/https://www.qualitymeasures.ahrq.gov/summaries/summary/46814/Stable-coronary-artery-disease-percentage-of-patients-with-stable-coronary-artery-disease-who-have-demonstrated-an-understanding-of-how-to-respond-in-an-acute-cardiac-event-by-teaching-back-as-to-how-they-would-respond-in-the-case-of-acute-cardiac-event\n",
      "http://wayback.archive-it.org/all/20160930145248/https://www.qualitymeasures.ahrq.gov/summaries/summary/46815/Stable-coronary-artery-disease-percentage-of-patients-who-smoke-with-documentation-in-the-medical-record-that-advice-to-quit-was-provided-andor-help-to-quit-was-provided\n",
      "http://wayback.archive-it.org/all/20160930145321/https://www.qualitymeasures.ahrq.gov/summaries/summary/46816/Stable-coronary-artery-disease-percentage-of-patients-with-cardiovascular-disease-who-received-an-annual-influenza-vaccination\n",
      "http://wayback.archive-it.org/all/20160930145355/https://www.qualitymeasures.ahrq.gov/summaries/summary/46817/Stable-coronary-artery-disease-percentage-of-patients-with-documentation-in-the-medical-record-of-receiving-a-pneumonia-vaccination-according-to-the-CDC-recommendations\n",
      "http://wayback.archive-it.org/all/20160930145338/https://www.qualitymeasures.ahrq.gov/summaries/summary/46818/Stable-coronary-artery-disease-percentage-of-patients-with-documentation-in-the-medical-record-of-physical-activity-goal-and-when-the-goal-was-met\n",
      "http://wayback.archive-it.org/all/20160930145254/https://www.qualitymeasures.ahrq.gov/summaries/summary/46819/Stable-coronary-artery-disease-percentage-of-patients-who-were-screened-for-depression-using-the-PHQ9\n",
      "http://wayback.archive-it.org/all/20160930145415/https://www.qualitymeasures.ahrq.gov/summaries/summary/46820/Stable-coronary-artery-disease-percentage-of-patients-with-documentation-in-the-medical-record-that-an-LDL-was-obtained-within-the-last-12-months-with-an-LDL-less-than-100-mgdL-Consider-less-than-70-mgdL-for-highrisk-patient\n",
      "http://wayback.archive-it.org/all/20160930145313/https://www.qualitymeasures.ahrq.gov/summaries/summary/46821/Stable-coronary-artery-disease-percentage-of-patients-with-a-documented-blood-pressure-in-the-medical-record-of-14090-mmHg-or-less\n",
      "http://wayback.archive-it.org/all/20160930145326/https://www.qualitymeasures.ahrq.gov/summaries/summary/46822/Stable-coronary-artery-disease-percentage-of-patients-with-diabetes-with-a-documented-HbA1c-of-less-than-70-or-meeting-the-patients-individualized-HbA1c-goal\n",
      "http://wayback.archive-it.org/all/20160930145332/https://www.qualitymeasures.ahrq.gov/summaries/summary/46823/Stable-coronary-artery-disease-percentage-of-patients-with-diagnosis-of-stable-coronary-artery-disease-with-systolic-CHF-ejection-fraction-less-than-or-equal-to-40-who-are-prescribed-an-ACE-inhibitor-or-ARB\n",
      "http://wayback.archive-it.org/all/20160930145302/https://www.qualitymeasures.ahrq.gov/summaries/summary/46824/Stable-coronary-artery-disease-percentage-of-patients-with-a-diagnosis-of-stable-coronary-artery-disease-and-chronic-kidney-disease-who-are-prescribed-an-ACE-inhibitor-or-ARB\n",
      "http://wayback.archive-it.org/all/20160930145308/https://www.qualitymeasures.ahrq.gov/summaries/summary/46825/Stable-coronary-artery-disease-percentage-of-patients-with-a-diagnosis-of-stable-coronary-artery-disease-and-hypertension-who-are-prescribed-an-ACE-inhibitor-or-ARB\n",
      "http://wayback.archive-it.org/all/20160930145345/https://www.qualitymeasures.ahrq.gov/summaries/summary/46826/Stable-coronary-artery-disease-percentage-of-patients-with-documentation-in-the-medical-record-of-prognostic-assessment-preceding-or-following-a-course-of-pharmacologic-therapy\n",
      "http://wayback.archive-it.org/all/20160930145205/https://www.qualitymeasures.ahrq.gov/summaries/summary/46827/Prevention-and-management-of-obesity-for-adults-percentage-of-patients-who-have-an-annual-BMI-measured-and-documented\n",
      "http://wayback.archive-it.org/all/20160930145228/https://www.qualitymeasures.ahrq.gov/summaries/summary/46828/Prevention-and-management-of-obesity-for-adults-percentage-of-patients-with-a-BMI-greater-than-or-equal-to-25-who-received-education-and-counseling-for-weight-management-strategies-that-include-nutrition-physical-activity-lifestyle-changes-medication-therapy-a\n",
      "http://wayback.archive-it.org/all/20160930145220/https://www.qualitymeasures.ahrq.gov/summaries/summary/46829/Prevention-and-management-of-obesity-for-adults-percentage-of-patients-with-a-BMI-greater-than-or-equal-to-25-who-have-reduced-their-weight-by-5\n",
      "http://wayback.archive-it.org/all/20160930145242/https://www.qualitymeasures.ahrq.gov/summaries/summary/46830/Prevention-and-management-of-obesity-for-adults-percentage-of-patients-with-BMI-greater-than-or-equal-to-25-who-have-30-minutes-of-any-type-of-physical-activity-five-times-per-week-documented\n",
      "http://wayback.archive-it.org/all/20160930145214/https://www.qualitymeasures.ahrq.gov/summaries/summary/46831/Prevention-and-management-of-obesity-for-adults-percentage-of-patients-with-a-BMI-greater-than-or-equal-to-25-who-have-reduced-their-weight-by-10\n",
      "http://wayback.archive-it.org/all/20160930145233/https://www.qualitymeasures.ahrq.gov/summaries/summary/46832/Prevention-and-management-of-obesity-for-adults-percentage-of-patients-with-a-BMI-greater-than-or-equal-to-40-who-have-been-provided-with-a-referral-to-a-bariatric-specialist\n",
      "http://wayback.archive-it.org/all/20160930145552/https://www.qualitymeasures.ahrq.gov/summaries/summary/47032/Heart-failure-in-adults-percentage-of-patients-with-heart-failure-diagnosis-and-LVSD-who-at-the-last-clinic-visit-met-the-following-if-eligible-prescribed-or-were-on-ACEIARB-prescribed-or-were-on-betablocker-therapy-and-a-nonsmoker\n",
      "http://wayback.archive-it.org/all/20160930145727/https://www.qualitymeasures.ahrq.gov/summaries/summary/47033/Heart-failure-in-adults-percentage-of-patients-with-heart-failure-diagnosis-who-were-educated-on-the-management-of-their-condition\n",
      "http://wayback.archive-it.org/all/20160930145648/https://www.qualitymeasures.ahrq.gov/summaries/summary/47034/Heart-failure-in-adults-percentage-of-patients-with-heart-failure-diagnosis-who-have-a-followup-appointment-with-their-primary-care-clinician-within-seven-days-of-hospital-discharge\n",
      "http://wayback.archive-it.org/all/20160930145518/https://www.qualitymeasures.ahrq.gov/summaries/summary/47035/Heart-failure-in-adults-percentage-of-heart-failure-patients-who-are-current-smokers-or-tobacco-users-who-received-smoking-cessation-advice-or-counseling-in-primary-care\n",
      "http://wayback.archive-it.org/all/20160930145754/https://www.qualitymeasures.ahrq.gov/summaries/summary/47110/Prevention-and-management-of-obesity-for-children-and-adolescents-percentage-of-patients-who-have-an-annual-BMI-measured\n",
      "http://wayback.archive-it.org/all/20160930145828/https://www.qualitymeasures.ahrq.gov/summaries/summary/47111/Prevention-and-management-of-obesity-for-children-and-adolescents-percentage-of-patients-with-BMI-screening-whose-BMI-percentile-is-between-85-and-94\n",
      "http://wayback.archive-it.org/all/20160930145835/https://www.qualitymeasures.ahrq.gov/summaries/summary/47112/Prevention-and-management-of-obesity-for-children-and-adolescents-percentage-of-patients-with-BMI-screening-whose-BMI-percentile-is-greater-than-or-equal-to-95\n",
      "http://wayback.archive-it.org/all/20160930145821/https://www.qualitymeasures.ahrq.gov/summaries/summary/47113/Prevention-and-management-of-obesity-for-children-and-adolescents-percentage-of-patients-with-BMI-screening-who-have-received-education-regarding-weight-management-strategies-that-include-nutrition-and-physical-activity\n",
      "http://wayback.archive-it.org/all/20160930145811/https://www.qualitymeasures.ahrq.gov/summaries/summary/47114/Prevention-and-management-of-obesity-for-children-and-adolescents-percentage-of-patients-with-BMI-screening-percentile-greater-than-or-equal-to-85-who-have-cholesterol-screening\n",
      "http://wayback.archive-it.org/all/20160930145801/https://www.qualitymeasures.ahrq.gov/summaries/summary/47115/Prevention-and-management-of-obesity-for-children-and-adolescents-percentage-of-patients-with-BMI-screening-percentile-greater-than-or-equal-85-whose-BMI-percentile-decreased-within-12-months-of-screening\n",
      "http://wayback.archive-it.org/all/20160930145903/https://www.qualitymeasures.ahrq.gov/summaries/summary/47331/Preventive-services-for-children-and-adolescents-percentage-of-patients-who-by-age-13-years-were-uptodate-with-recommended-adolescent-immunizations-1-one-HPV---human-papillomavirus-vaccine-by-age-13-2-one-MCV4---meningococcal-3-one-Tdap---tetanus-diphtheria-to\n",
      "http://wayback.archive-it.org/all/20160930145911/https://www.qualitymeasures.ahrq.gov/summaries/summary/47332/Preventive-services-for-children-and-adolescents-percentage-of-sexually-active-women-age-25-years-and-younger-who-have-had-screening-for-chlamydia\n",
      "http://wayback.archive-it.org/all/20160930145843/https://www.qualitymeasures.ahrq.gov/summaries/summary/47333/Preventive-services-for-children-and-adolescents-percentage-of-newborns-who-have-had-neonatal-screening-for-hemoglobinopathies-phenylketonuria-and-hypothyroidism-in-the-first-week-of-life\n",
      "http://wayback.archive-it.org/all/20160930145850/https://www.qualitymeasures.ahrq.gov/summaries/summary/47334/Preventive-services-for-children-and-adolescents-percentage-of-patients-age-five-years-and-younger-who-have-had-vision-impairment-screening\n",
      "http://wayback.archive-it.org/all/20160930145923/https://www.qualitymeasures.ahrq.gov/summaries/summary/47659/Diagnosis-and-treatment-of-osteoporosis-percentage-of-patients-who-were-assessed-for-risk-factors-for-osteoporosis-during-an-annual-preventive-visit\n",
      "http://wayback.archive-it.org/all/20160930145929/https://www.qualitymeasures.ahrq.gov/summaries/summary/47660/Diagnosis-and-treatment-of-osteoporosis-percentage-of-patients-who-were-found-to-be-at-risk-for-bone-loss-or-fractures-who-had-bone-densitometry\n",
      "http://wayback.archive-it.org/all/20160930145954/https://www.qualitymeasures.ahrq.gov/summaries/summary/47661/Diagnosis-and-treatment-of-osteoporosis-percentage-of-patients-with-whom-adequacy-of-vitamin-D-and-calcium-dietary-supplementation-were-addressed\n",
      "http://wayback.archive-it.org/all/20160930145916/https://www.qualitymeasures.ahrq.gov/summaries/summary/47662/Diagnosis-and-treatment-of-osteoporosis-percentage-of-patients-diagnosed-with-osteoporosis-who-are-on-pharmacologic-therapy\n",
      "http://wayback.archive-it.org/all/20160930145944/https://www.qualitymeasures.ahrq.gov/summaries/summary/47663/Diagnosis-and-treatment-of-osteoporosis-percentage-of-patients-with-a-history-of-lowimpact-fragility-fracture-who-were-assessed-for-osteoporosis\n",
      "http://wayback.archive-it.org/all/20160930145939/https://www.qualitymeasures.ahrq.gov/summaries/summary/47664/Diagnosis-and-treatment-of-osteoporosis-percentage-of-patients-with-a-history-of-lowimpact-fragility-fracture-assessed-for-secondary-causes-of-osteoporosis\n",
      "http://wayback.archive-it.org/all/20160930145934/https://www.qualitymeasures.ahrq.gov/summaries/summary/47665/Diagnosis-and-treatment-of-osteoporosis-percentage-of-patients-with-a-history-of-lowimpact-fragility-fracture-and-diagnosed-with-osteoporosis-due-to-secondary-causes-offered-treatment\n",
      "http://wayback.archive-it.org/all/20160930145949/https://www.qualitymeasures.ahrq.gov/summaries/summary/47666/Diagnosis-and-treatment-of-osteoporosis-percentage-of-patients-with-a-lowimpact-fragility-fracture-who-are-taking-calcium-and-vitamin-D-dietary-supplementation\n",
      "http://wayback.archive-it.org/all/20160930150032/https://www.qualitymeasures.ahrq.gov/summaries/summary/47725/Palliative-care-for-adults-percentage-of-adult-patients-with-a-serious-illness-who-have-been-screened-for-palliative-care\n",
      "http://wayback.archive-it.org/all/20160930150042/https://www.qualitymeasures.ahrq.gov/summaries/summary/47726/Palliative-care-for-adults-percentage-of-clinicians-who-have-education-and-training-regarding-palliative-care-concepts\n",
      "http://wayback.archive-it.org/all/20160930150048/https://www.qualitymeasures.ahrq.gov/summaries/summary/47727/Palliative-care-for-adults-percentage-of-clinicians-who-have-training-in-the-use-of-scripting-for-palliative-care-discussions\n",
      "http://wayback.archive-it.org/all/20160930150026/https://www.qualitymeasures.ahrq.gov/summaries/summary/47728/Palliative-care-for-adults-percentage-of-adult-patients-with-a-serious-illness-who-have-been-assessed-for-the-domains-of-palliative-care\n",
      "http://wayback.archive-it.org/all/20160930150020/https://www.qualitymeasures.ahrq.gov/summaries/summary/47729/Palliative-care-for-adults-percentage-of-adult-patients-with-a-serious-illness-who-have-a-symptom-assessment-documented-in-the-medical-record\n",
      "http://wayback.archive-it.org/all/20160930150052/https://www.qualitymeasures.ahrq.gov/summaries/summary/47730/Palliative-care-for-adults-percentage-of-patients-who-have-treatment-options-patient-goals-and-a-plan-of-care-across-care-continuum-documented\n",
      "http://wayback.archive-it.org/all/20160930150014/https://www.qualitymeasures.ahrq.gov/summaries/summary/47731/Palliative-care-for-adults-percentage-of-adult-patients-with-a-serious-illness-who-have-a-revised-documented-care-plan-that-addresses-the-domains-of-palliative-care\n",
      "http://wayback.archive-it.org/all/20160930150005/https://www.qualitymeasures.ahrq.gov/summaries/summary/47732/Palliative-care-for-adults-percentage-of-adult-patients-with-a-serious-illness-who-have-a-revised-symptom-assessment-in-the-medical-record\n",
      "http://wayback.archive-it.org/all/20160930150037/https://www.qualitymeasures.ahrq.gov/summaries/summary/47733/Palliative-care-for-adults-percentage-of-adult-patients-with-a-serious-illness-who-have-documentation-in-the-medical-record-of-a-completed-advance-directive\n",
      "http://wayback.archive-it.org/all/20160930145959/https://www.qualitymeasures.ahrq.gov/summaries/summary/47734/Palliative-care-for-adults-percentage-of-adult-patients-with-a-serious-illness-who-have-a-completed-PhysicianProvider-Order-for-LifeSustaining-Treatment-POLST-form-documented-in-the-medical-record\n",
      "http://wayback.archive-it.org/all/20160930150156/https://www.qualitymeasures.ahrq.gov/summaries/summary/47735/Assessment-and-management-of-chronic-pain-percentage-of-patients-diagnosed-with-chronic-pain-with-functional-outcome-goals-documented-in-the-medical-record\n",
      "http://wayback.archive-it.org/all/20160930150201/https://www.qualitymeasures.ahrq.gov/summaries/summary/47736/Assessment-and-management-of-chronic-pain-percentage-of-patients-diagnosed-with-chronic-pain-with-referral-to-physical-rehabilitation-andor-behavioral-management-therapy\n",
      "http://wayback.archive-it.org/all/20160930150206/https://www.qualitymeasures.ahrq.gov/summaries/summary/47737/Assessment-and-management-of-chronic-pain-percentage-of-patients-with-chronic-pain-diagnosis-with-documentation-of-a-pain-assessment-completed-at-initial-visit-using-a-standardized-tool-that-addresses-pain-intensity-location-pattern-mechanism-of-pain-current-f\n",
      "http://wayback.archive-it.org/all/20160930150145/https://www.qualitymeasures.ahrq.gov/summaries/summary/47738/Assessment-and-management-of-chronic-pain-percentage-of-patients-diagnosed-with-chronic-pain-with-documentation-of-receiving-education-regarding-their-diagnosis-of-chronic-pain-medications-importance-of-physical-activity-andor-any-interventional-procedures-in-\n",
      "http://wayback.archive-it.org/all/20160930150140/https://www.qualitymeasures.ahrq.gov/summaries/summary/47739/Assessment-and-management-of-chronic-pain-percentage-of-patients-diagnosed-with-chronic-pain-with-documentation-of-reassessment-of-pain-at-followup-visits-using-a-standardized-tool-that-addresses-pain-intensity-location-pattern-and-current-functional-status\n",
      "http://wayback.archive-it.org/all/20160930150151/https://www.qualitymeasures.ahrq.gov/summaries/summary/47740/Assessment-and-management-of-chronic-pain-percentage-of-patients-diagnosed-with-chronic-pain-with-documentation-of-screening-for-major-depression-and-chemical-dependency\n",
      "http://wayback.archive-it.org/all/20160930150124/https://www.qualitymeasures.ahrq.gov/summaries/summary/47741/Assessment-and-management-of-chronic-pain-percentage-of-patients-diagnosed-with-chronic-pain-who-have-documentation-of-a-plan-of-care-that-addresses-personal-goals-sleep-physical-activity-stress-management-and-pain-reduction-in-the-medical-record-and-identifie\n",
      "http://wayback.archive-it.org/all/20160930150058/https://www.qualitymeasures.ahrq.gov/summaries/summary/47742/Assessment-and-management-of-chronic-pain-percentage-of-chronic-pain-patients-who-are-referred-to-diagnostic-andor-therapeutic-procedures-if-the-goals-for-pain-control-or-functional-status-have-not-been-met\n",
      "http://wayback.archive-it.org/all/20160930150130/https://www.qualitymeasures.ahrq.gov/summaries/summary/47743/Assessment-and-management-of-chronic-pain-percentage-of-patients-diagnosed-with-chronic-pain-who-have-not-met-pain-control-or-functional-status-goals-who-are-referred-to-pain-specialist-or-interdisciplinary-pain-team\n",
      "http://wayback.archive-it.org/all/20160930150135/https://www.qualitymeasures.ahrq.gov/summaries/summary/47744/Assessment-and-management-of-chronic-pain-percentage-of-patients-diagnosed-with-chronic-pain-with-a-diagnosis-of-neuropathic-pain-who-are-prescribed-a-sedative-analgesic-OR-anticonvulsant-prior-to-use-of-opioids\n",
      "http://wayback.archive-it.org/all/20160930150114/https://www.qualitymeasures.ahrq.gov/summaries/summary/47745/Assessment-and-management-of-chronic-pain-percentage-of-patients-diagnosed-with-chronic-pain-who-are-receiving-opioids-who-have-documentation-of-the-four-As-assessment-1-the-degree-of-analgesia-2-current-opioidrelated-side-effects-3-current-functional-status-a\n",
      "http://wayback.archive-it.org/all/20160930150109/https://www.qualitymeasures.ahrq.gov/summaries/summary/47746/Assessment-and-management-of-chronic-pain-percentage-of-patients-diagnosed-with-chronic-pain-who-are-prescribed-an-opioid-who-have-an-opioid-agreement-form-and-urine-toxicology-screen-documented-in-the-medical-record\n",
      "http://wayback.archive-it.org/all/20160930150119/https://www.qualitymeasures.ahrq.gov/summaries/summary/47747/Assessment-and-management-of-chronic-pain-percentage-of-patients-diagnosed-with-chronic-pain-who-are-screened-for-chemical-dependency-before-being-prescribed-opioid-medication\n",
      "http://wayback.archive-it.org/all/20160930150103/https://www.qualitymeasures.ahrq.gov/summaries/summary/47748/Assessment-and-management-of-chronic-pain-percentage-of-patients-diagnosed-with-chronic-pain-who-are-prescribed-an-opioid-at-a-dose-less-than-100-mg-per-day-of-morphine\n",
      "http://wayback.archive-it.org/all/20160930150239/https://www.qualitymeasures.ahrq.gov/summaries/summary/47808/Lipid-management-in-adults-percentage-of-patients-with-established-atherosclerotic-cardiovascular-disease-ASCVD-or-a-10year-risk-for-CHD-greater-than-or-equal-to-10-or-diabetes-who-are-on-a-statin-or-have-LDL-less-than-100-mldL-within-a-12month-period\n",
      "http://wayback.archive-it.org/all/20160930150231/https://www.qualitymeasures.ahrq.gov/summaries/summary/47809/Lipid-management-in-adults-percentage-of-patients-with-established-atherosclerotic-cardiovascular-disease-ASCVD-or-10year-CHD-risk-greater-than-or-equal-to-10-or-diabetes-and-on-lipidlowering-medication-who-have-a-fasting-lipid-panel-within-24-months-of-medica\n",
      "http://wayback.archive-it.org/all/20160930150218/https://www.qualitymeasures.ahrq.gov/summaries/summary/47810/Lipid-management-in-adults-percentage-of-patients-with-established-ASCVD-or-a-10year-CHD-risk-greater-than-or-equal-to-10-or-diabetes-on-lipidlowering-medication-and-most-recent-LDL-greater-than-100-mgdL-who-are-prescribed-a-maximal-recommended-dose-of-a-poten\n",
      "http://wayback.archive-it.org/all/20160930150212/https://www.qualitymeasures.ahrq.gov/summaries/summary/47811/Lipid-management-in-adults-percentage-of-patients-with-established-ASCVD-or-10year-CHD-risk-greater-than-or-equal-to-10-or-diabetes-and-on-lipidlowering-therapy-who-remain-on-lipidlowering-pharmacotherapy-12-months-after-therapy-was-prescribed\n",
      "http://wayback.archive-it.org/all/20160930150332/https://www.qualitymeasures.ahrq.gov/summaries/summary/48383/Perioperative-protocol-percentage-of-patients-undergoing-elective-nonhighrisk-surgery-with-a-preoperative-basic-health-assessment-completed-prior-to-the-day-of-the-scheduled-procedure\n",
      "http://wayback.archive-it.org/all/20160930150309/https://www.qualitymeasures.ahrq.gov/summaries/summary/48384/Perioperative-protocol-percentage-of-patients-undergoing-elective-nonhighrisk-surgery-having-laboratory-testsimaging-unrelated-to-positive-findings-on-preoperative-basic-health-assessment\n",
      "http://wayback.archive-it.org/all/20160930150258/https://www.qualitymeasures.ahrq.gov/summaries/summary/48385/Perioperative-protocol-percentage-of-patients-undergoing-cataract-surgery-who-have-electrocardiograms-performed-as-part-of-the-preoperative-assessment-prior-to-cataract-surgery\n",
      "http://wayback.archive-it.org/all/20160930150348/https://www.qualitymeasures.ahrq.gov/summaries/summary/48386/Perioperative-protocol-percentage-of-patients-with-comorbidities-undergoing-elective-nonhighrisk-surgery-who-have-appropriate-management-of-comorbidities-prior-to-surgery-including-antithrombotic-therapy-recent-coronary-stentantiplatelet-therapy-betablocker-th\n",
      "http://wayback.archive-it.org/all/20160930150356/https://www.qualitymeasures.ahrq.gov/summaries/summary/48387/Perioperative-protocol-percentage-of-patients-with-comorbidities-undergoing-elective-nonhighrisk-surgery-who-have-preoperative-recommendations-documentedcommunicated-to-the-patient-andor-surgical-facility-for-all-of-the-following-applicable-comorbidities-antit\n",
      "http://wayback.archive-it.org/all/20160930150402/https://www.qualitymeasures.ahrq.gov/summaries/summary/48388/Perioperative-protocol-percentage-of-patients-with-comorbidities-who-have-preoperative-education-documented-for-all-specified-applicable-comorbidities\n",
      "http://wayback.archive-it.org/all/20160930150342/https://www.qualitymeasures.ahrq.gov/summaries/summary/48389/Perioperative-protocol-percentage-of-patients-who-have-canceled-or-delayed-nonhighrisk-surgical-procedures-due-to-incomplete-preoperative-basic-health-assessment-documentation\n",
      "http://wayback.archive-it.org/all/20160930150252/https://www.qualitymeasures.ahrq.gov/summaries/summary/48390/Perioperative-protocol-percentage-of-canceled-or-delayed-surgical-procedures-due-to-ineffective-communication-regarding-patient-information-as-defined-by-organizational-procedures\n",
      "http://wayback.archive-it.org/all/20160930150446/https://www.qualitymeasures.ahrq.gov/summaries/summary/48391/Perioperative-protocol-percentage-of-wrong-surgery-events-per-month\n",
      "http://wayback.archive-it.org/all/20160930150440/https://www.qualitymeasures.ahrq.gov/summaries/summary/48392/Perioperative-protocol-percentage-of-unintentionally-retained-foreign-objects-in-surgical-cases-per-month\n",
      "http://wayback.archive-it.org/all/20160930150411/https://www.qualitymeasures.ahrq.gov/summaries/summary/48393/Perioperative-protocol-percentage-of-preoperative-wound-infections-by-wound-classifications-Class-I-clean-Class-II-clean-contaminated-and-Class-III-contaminated\n",
      "http://wayback.archive-it.org/all/20160930150435/https://www.qualitymeasures.ahrq.gov/summaries/summary/48394/Perioperative-protocol-percentage-of-surgical-patients-with-documentation-of-preoperative-verification-of-correct-patient-procedure-and-sitesidelevel\n",
      "http://wayback.archive-it.org/all/20160930150246/https://www.qualitymeasures.ahrq.gov/summaries/summary/48395/Perioperative-protocol-percentage-of-appropriate-surgical-patients-who-had-their-site-marked-by-the-surgeon-in-preoperative-with-hisher-initials\n",
      "http://wayback.archive-it.org/all/20160930150417/https://www.qualitymeasures.ahrq.gov/summaries/summary/48396/Perioperative-protocol-percentage-of-surgical-cases-in-which-a-verbal-active-TimeOut-has-been-conducted-by-all-appropriate-members-of-the-surgical-team-prior-to-incision\n",
      "http://wayback.archive-it.org/all/20160930150430/https://www.qualitymeasures.ahrq.gov/summaries/summary/48397/Perioperative-protocol-percentage-of-surgical-cases-where-the-baseline-count-was-conducted-prior-to-the-patient-arriving-in-the-operatingprocedure-room\n",
      "http://wayback.archive-it.org/all/20160930150424/https://www.qualitymeasures.ahrq.gov/summaries/summary/48398/Perioperative-protocol-percentage-of-surgical-cases-where-counts-were-not-reconciled-and-imaging-was-performed\n",
      "http://wayback.archive-it.org/all/20160930150458/https://www.qualitymeasures.ahrq.gov/summaries/summary/48462/Diagnosis-and-management-of-type-2-diabetes-mellitus-T2DM-in-adults-percentage-of-patients-ages-18-to-75-years-old-with-T2DM-who-are-optimally-managed-according-to-the-specified-components\n",
      "http://wayback.archive-it.org/all/20160930150503/https://www.qualitymeasures.ahrq.gov/summaries/summary/48468/Diagnosis-and-management-of-type-2-diabetes-mellitus-T2DM-in-adults-percentage-of-patients-ages-18-to-75-years-old-with-T2DM-with-poorly-controlled-glucose-or-any-of-the-specified-cardiovascular-risk-factors\n",
      "http://wayback.archive-it.org/all/20160930150452/https://www.qualitymeasures.ahrq.gov/summaries/summary/48469/Diagnosis-and-management-of-type-2-diabetes-mellitus-T2DM-in-adults-percentage-of-newly-diagnosed-patients-who-are-advised-about-lifestyle-modification-and-nutrition-therapy-within-one-year-of-diagnosis\n",
      "http://wayback.archive-it.org/all/20160930150518/https://www.qualitymeasures.ahrq.gov/summaries/summary/48470/Diagnosis-and-management-of-type-2-diabetes-mellitus-T2DM-in-adults-percentage-of-patients-ages-40-to-75-years-old-with-untreated-LDL-greater-than-70-mgdL-who-are-prescribed-statin-therapy\n",
      "http://wayback.archive-it.org/all/20160930150527/https://www.qualitymeasures.ahrq.gov/summaries/summary/48471/Diagnosis-and-management-of-type-2-diabetes-mellitus-T2DM-in-adults-percentage-of-patients-with-established-ASCVD-with-documented-aspirin-use\n",
      "http://wayback.archive-it.org/all/20170608152407/https://www.qualitymeasures.ahrq.gov/summaries/summary/50490/cancer-30day-unplanned-readmission-rate-for-cancer-patients\n"
     ]
    }
   ],
   "source": [
    "from urllib.parse import urlparse\n",
    "\n",
    "archivedomains = {}\n",
    "\n",
    "for timemap in timemaps:\n",
    "    \n",
    "    for memento in timemap:\n",
    "        urim = memento['uri']\n",
    "        archivedomain = urlparse(urim).netloc.split(':')[0]\n",
    "        archivedomains.setdefault(archivedomain, 0)\n",
    "        archivedomains[archivedomain] += 1\n",
    "        \n",
    "        if 'archive-it.org' in archivedomain:\n",
    "            print(urim)\n",
    "            break"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'web.archive.org': 9494, 'wayback.archive-it.org': 216}"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "archivedomains"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "9710"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "total_mementos = 0\n",
    "\n",
    "for ad in archivedomains:\n",
    "    count = archivedomains[ad]\n",
    "    total_mementos += count\n",
    "    \n",
    "total_mementos"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x720 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "\"\"\"\n",
    "========\n",
    "Barchart\n",
    "========\n",
    "\n",
    "A bar plot with errorbars and height labels on individual bars\n",
    "\"\"\"\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "N = 2\n",
    "archivecounts = (9494, 216)\n",
    "# men_std = (2, 3, 4, 1, 2)\n",
    "\n",
    "ind = np.arange(N)  # the x locations for the groups\n",
    "width = 0.35       # the width of the bars\n",
    "\n",
    "fig, ax = plt.subplots()\n",
    "fig.set_size_inches(10, 10)\n",
    "rects1 = ax.bar(ind, archivecounts, width, align='center', color=\"#b2df8a\")\n",
    "\n",
    "# women_means = (25, 32, 34, 20, 25)\n",
    "# women_std = (3, 5, 2, 3, 3)\n",
    "# rects2 = ax.bar(ind + width, women_means, width, color='y', yerr=women_std)\n",
    "\n",
    "# add some text for labels, title and axes ticks\n",
    "ax.set_ylabel('Count of Mementos')\n",
    "ax.set_title('Count of Mementos Per Archive\\nfor other pages \\n at qualitymeasures.ahrq.gov')\n",
    "ax.set_xticks(ind)\n",
    "ax.set_xticklabels(('Internet Archive', 'Archive-It'))\n",
    "ax.set_ylim(0, 11000)\n",
    "\n",
    "# ax.legend((rects1[0], rects2[0]), ('Men', 'Women'))\n",
    "\n",
    "\n",
    "def autolabel(rects):\n",
    "    \"\"\"\n",
    "    Attach a text label above each bar displaying its height\n",
    "    \"\"\"\n",
    "    for rect in rects:\n",
    "        height = rect.get_height()\n",
    "        ax.text(rect.get_x() + rect.get_width()/2., 1.05*height,\n",
    "                '%d' % int(height),\n",
    "                ha='center', va='bottom')\n",
    "\n",
    "autolabel(rects1)\n",
    "# autolabel(rects2)\n",
    "\n",
    "for tick in ax.get_xticklabels():\n",
    "    tick.set_rotation(45)\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
